UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
(Mark One)
x | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended September 30, 2016
or
¨ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to
Commission File Number 000-53969
SENTIO HEALTHCARE PROPERTIES, INC.
(Exact name of registrant as specified in its charter)
MARYLAND | 20-5721212 |
(State or other jurisdiction of | (I.R.S. Employer |
incorporation or organization) | Identification No.) |
189 South Orange Avenue, Suite 1700, | |
Orlando, FL | 32801 |
(Address of principal executive offices) | (Zip Code) |
407-999-7679
(Registrant’s telephone number, including area code)
Not Applicable
(Former name, former address and former fiscal year, if changed since last report)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by section 13 or 15(d) of the Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. x Yes ¨ No
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (Sec.232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). x Yes ¨ No
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See the definitions of “large accelerated filer”, “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. Check one:
Large accelerated filer | ¨ | Accelerated filer | ¨ |
Non-accelerated filer | x | Smaller reporting company | ¨ |
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ¨ Yes x No
As of November 10, 2016, there were 11,531,654 shares of common stock of Sentio Healthcare Properties, Inc. outstanding.
Table of Contents
PART I — FINANCIAL INFORMATION
FORM 10-Q
SENTIO HEALTHCARE PROPERTIES, INC.
TABLE OF CONTENTS
2 |
SENTIO HEALTHCARE PROPERTIES, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
September 30, | December 31, | |||||||
2016 | 2015 | |||||||
(Unaudited) | ||||||||
ASSETS | ||||||||
Cash and cash equivalents | $ | 36,282,000 | $ | 22,801,000 | ||||
Investments in real estate: | ||||||||
Land | 47,196,000 | 47,196,000 | ||||||
Buildings and improvements, net | 388,773,000 | 397,234,000 | ||||||
Furniture, fixtures and vehicles, net | 11,890,000 | 12,660,000 | ||||||
Construction in progress | 11,767,000 | 5,168,000 | ||||||
Intangible lease assets, net | 4,929,000 | 6,731,000 | ||||||
464,555,000 | 468,989,000 | |||||||
Real estate note receivable | 31,580,000 | 15,427,000 | ||||||
Investment in unconsolidated entities | 567,000 | 880,000 | ||||||
Tenant and other receivables, net | 5,490,000 | 5,751,000 | ||||||
Deferred costs and other assets | 9,965,000 | 8,636,000 | ||||||
Restricted cash | 6,405,000 | 6,748,000 | ||||||
Goodwill | 5,965,000 | 5,965,000 | ||||||
Total assets | $ | 560,809,000 | $ | 535,197,000 | ||||
LIABILITIES AND EQUITY | ||||||||
Liabilities: | ||||||||
Notes payable, net | $ | 353,156,000 | $ | 335,288,000 | ||||
Accounts payable and accrued liabilities | 18,271,000 | 22,575,000 | ||||||
Prepaid rent and security deposits | 5,314,000 | 5,368,000 | ||||||
Distributions payable | 1,448,000 | 1,450,000 | ||||||
Total liabilities | 378,189,000 | 364,681,000 | ||||||
Equity: | ||||||||
Preferred Stock Series C, $0.01 par value; 1,000 shares authorized; 1,000 and 1,000 shares issued and outstanding at September 30, 2016 and December 31, 2015, respectively | - | - | ||||||
Common stock, $0.01 par value; 580,000,000 shares authorized; 11,524,370 and 11,502,617 shares issued and outstanding at September 30, 2016 and December 31, 2015, respectively | 115,000 | 115,000 | ||||||
Additional paid-in capital | 57,338,000 | 61,385,000 | ||||||
Accumulated deficit | (29,629,000 | ) | (27,612,000 | ) | ||||
Total stockholders' equity | 27,824,000 | 33,888,000 | ||||||
Noncontrolling interests: | ||||||||
Series B convertible preferred OP units | 150,416,000 | 132,164,000 | ||||||
Other noncontrolling interest | 4,380,000 | 4,464,000 | ||||||
Total equity | 182,620,000 | 170,516,000 | ||||||
Total liabilities and equity | $ | 560,809,000 | $ | 535,197,000 |
The accompanying notes are an integral part of these condensed consolidated financial statements.
3 |
SENTIO HEALTHCARE PROPERTIES, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)
Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||
2016 | 2015 | 2016 | 2015 | |||||||||||||
Revenues: | ||||||||||||||||
Rental revenues | $ | 23,164,000 | $ | 21,053,000 | $ | 67,933,000 | $ | 58,450,000 | ||||||||
Resident fees and services | 8,263,000 | 7,886,000 | 24,708,000 | 23,345,000 | ||||||||||||
Tenant reimbursements and other income | 1,142,000 | 836,000 | 4,523,000 | 2,262,000 | ||||||||||||
32,569,000 | 29,775,000 | 97,164,000 | 84,057,000 | |||||||||||||
Expenses: | ||||||||||||||||
Property operating and maintenance | 20,879,000 | 19,595,000 | 61,927,000 | 54,431,000 | ||||||||||||
General and administrative | 373,000 | 383,000 | 1,475,000 | 2,086,000 | ||||||||||||
Asset management fees | 527,000 | 1,581,000 | 3,200,000 | 4,495,000 | ||||||||||||
Real estate acquisition costs | - | 111,000 | - | 1,461,000 | ||||||||||||
Depreciation and amortization | 3,763,000 | 5,459,000 | 12,717,000 | 15,434,000 | ||||||||||||
25,542,000 | 27,129,000 | 79,319,000 | 77,907,000 | |||||||||||||
Income from operations | 7,027,000 | 2,646,000 | 17,845,000 | 6,150,000 | ||||||||||||
Other (income) expense: | ||||||||||||||||
Interest expense, net | 4,169,000 | 3,571,000 | 11,801,000 | 10,258,000 | ||||||||||||
Change in fair value of contingent consideration | (103,000 | ) | 402,000 | 203,000 | 1,002,000 | |||||||||||
Equity in loss from unconsolidated entities | 35,000 | 86,000 | 163,000 | 259,000 | ||||||||||||
Loss on debt extinguishment | 378,000 | - | 378,000 | - | ||||||||||||
Net income (loss) before income taxes | 2,548,000 | (1,413,000 | ) | 5,300,000 | (5,369,000 | ) | ||||||||||
Income tax benefit | (410,000 | ) | (904,000 | ) | (1,310,000 | ) | (2,629,000 | ) | ||||||||
Net income (loss) | 2,958,000 | (509,000 | ) | 6,610,000 | (2,740,000 | ) | ||||||||||
Preferred return to series B preferred OP Units | 2,794,000 | 2,404,000 | 8,116,000 | 6,353,000 | ||||||||||||
Net income attributable to other noncontrolling interests | 216,000 | 43,000 | 511,000 | 277,000 | ||||||||||||
Net loss attributable to common stockholders | $ | (52,000 | ) | $ | (2,956,000 | ) | $ | (2,017,000 | ) | $ | (9,370,000 | ) | ||||
Basic and diluted weighted average number of common shares | 11,522,649 | 11,493,442 | 11,513,008 | 11,483,534 | ||||||||||||
Basic and diluted net income (loss) per common share attributable to common stockholders | $ | 0.00 | $ | (0.26 | ) | $ | (0.18 | ) | $ | (0.82 | ) |
The accompanying notes are an integral part of these condensed consolidated financial statements.
4 |
SENTIO HEALTHCARE PROPERTIES, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF EQUITY
For the Nine Months Ended September 30, 2016
(Unaudited)
Preferred Stock | Common Stock | Total | ||||||||||||||||||||||||||||||||||
Number of shares | Stock Par Value | Number of Shares | Stock Par Value | Additional Paid- In Capital | Accumulated Deficit | Stockholders' Equity | Noncontrolling Interest | Total | ||||||||||||||||||||||||||||
BALANCE - December 31, 2015 | 1,000 | $ | - | 11,502,617 | $ | 115,000 | $ | 61,385,000 | $ | (27,612,000 | ) | $ | 33,888,000 | $ | 136,628,000 | $ | 170,516,000 | |||||||||||||||||||
Issuance of Common Stock | - | - | 21,753 | - | 264,000 | - | 264,000 | - | 264,000 | |||||||||||||||||||||||||||
Issuance of Series B preferred OP Units, net | - | - | - | - | - | - | - | 18,251,000 | 18,251,000 | |||||||||||||||||||||||||||
Distributions | - | - | - | - | (4,311,000 | ) | - | (4,311,000 | ) | (8,710,000 | ) | (13,021,000 | ) | |||||||||||||||||||||||
Net (loss) income | - | - | - | - | - | (2,017,000 | ) | (2,017,000 | ) | 8,627,000 | 6,610,000 | |||||||||||||||||||||||||
BALANCE - September 30, 2016 | 1,000 | $ | - | 11,524,370 | $ | 115,000 | $ | 57,338,000 | $ | (29,629,000 | ) | $ | 27,824,000 | $ | 154,796,000 | $ | 182,620,000 |
The accompanying notes are an integral part of these condensed consolidated financial statements.
5 |
SENTIO HEALTHCARE PROPERTIES, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
Nine Months Ended September 30, | ||||||||
2016 | 2015 | |||||||
Cash flows from operating activities: | ||||||||
Net income (loss) | $ | 6,610,000 | $ | (2,740,000 | ) | |||
Adjustments to reconcile net income (loss) to net cash provided by operating activities: | ||||||||
Amortization of deferred financing costs | 720,000 | 655,000 | ||||||
Depreciation and amortization | 12,717,000 | 15,434,000 | ||||||
Straight-line rent and above/below market lease amortization | 12,000 | (638,000 | ) | |||||
Change in fair value of contingent consideration | 203,000 | 1,002,000 | ||||||
Amortization of loan discount/premium | (44,000 | ) | (45,000 | ) | ||||
Equity in loss from unconsolidated entities | 313,000 | 259,000 | ||||||
Loss on debt extinguishment | 378,000 | - | ||||||
Bad debt expense | 163,000 | 140,000 | ||||||
Deferred tax benefit | (1,310,000 | ) | (2,132,000 | ) | ||||
Changes in operating assets and liabilities: | ||||||||
Tenant and other receivables | 137,000 | (1,061,000 | ) | |||||
Deferred costs and other assets | (19,000 | ) | 321,000 | |||||
Restricted cash | (110,000 | ) | (299,000 | ) | ||||
Prepaid rent and tenant security deposits | (54,000 | ) | 1,593,000 | |||||
Accounts payable and accrued expenses | (1,166,000 | ) | 743,000 | |||||
Net cash provided by operating activities | 18,550,000 | 13,232,000 | ||||||
Cash flows from investing activities: | ||||||||
Real estate acquisitions | - | (69,311,000 | ) | |||||
Additions to real estate | (1,655,000 | ) | (2,314,000 | ) | ||||
Construction in progress | (6,599,000 | ) | (6,662,000 | ) | ||||
Real estate note receivable | (16,153,000 | ) | (7,732,000 | ) | ||||
Restricted cash | 453,000 | (211,000 | ) | |||||
Distributions from unconsolidated entities | - | 171,000 | ||||||
Acquisition deposits | - | (1,084,000 | ) | |||||
Net cash used in investing activities | (23,954,000 | ) | (87,143,000 | ) | ||||
Cash flows from financing activities: | ||||||||
Proceeds from issuance of series B preferred OP units, net | 18,251,000 | 36,650,000 | ||||||
Proceeds from notes payable | 130,777,000 | 43,674,000 | ||||||
Repayment of notes payable | (112,139,000 | ) | (2,316,000 | ) | ||||
Payment of contingent consideration | (3,421,000 | ) | - | |||||
Deferred financing costs | (1,824,000 | ) | (556,000 | ) | ||||
Distributions paid to series B preferred OP units and other noncontrolling interests | (8,710,000 | ) | (7,839,000 | ) | ||||
Distributions paid to stockholders | (4,049,000 | ) | (4,032,000 | ) | ||||
Restricted cash | - | (27,000 | ) | |||||
Offering costs | - | (18,000 | ) | |||||
Net cash provided by financing activities | 18,885,000 | 65,536,000 | ||||||
Net increase (decrease) in cash and cash equivalents | 13,481,000 | (8,375,000 | ) | |||||
Cash and cash equivalents - beginning of period | 22,801,000 | 35,564,000 | ||||||
Cash and cash equivalents - end of period | $ | 36,282,000 | $ | 27,189,000 | ||||
Supplemental disclosure of cash flow information: | ||||||||
Cash paid for interest | $ | 10,659,000 | $ | 9,391,000 | ||||
Cash paid for income taxes | $ | 164,000 | $ | 154,000 | ||||
Supplemental disclosure of non-cash financing and investing activities: | ||||||||
Note payable assumed in connection with a real estate acquisition | $ | - | $ | 18,350,000 | ||||
Equity contribution by noncontrolling interest | $ | - | $ | 1,498,000 | ||||
Consolidation of a previously held investment in an unconsolidated entity | $ | - | $ | 3,493,000 | ||||
Distributions declared not paid | $ | 1,449,000 | $ | 1,363,000 | ||||
Distributions reinvested | $ | 88,000 | $ | 5,000 | ||||
Accrued preferred stock offering costs | $ | - | $ | 136,000 | ||||
Accrued additions to real estate | $ | 80,000 | $ | 91,000 |
The accompanying notes are an integral part of these condensed consolidated financial statements.
6 |
SENTIO HEALTHCARE PROPERTIES, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
September 30, 2016
(Unaudited)
1. Organization
Sentio Healthcare Properties, Inc., a Maryland corporation, was formed on October 16, 2006 under the Maryland General Corporation Law for the purpose of engaging in the business of investing in and owning commercial real estate. As used in this report, the “Company”, “we”, “us” and “our” refer to Sentio Healthcare Properties, Inc. and its consolidated subsidiaries, except where context otherwise requires. Effective January 1, 2012, subject to certain restrictions and limitations, our business is managed by Sentio Investments, LLC, a Florida limited liability company that was formed on December 20, 2011 (the “Advisor”).
Sentio Healthcare Properties OP, LP, a Delaware limited partnership (the “Operating Partnership”), was formed on October 17, 2006. As of September 30, 2016, we owned 100% of the outstanding common units in the Operating Partnership and the HC Operating Partnership, LP, a subsidiary of the Operating Partnership. Pursuant to the terms of the KKR Equity Commitment (as described in Note 10), we have issued Series B Convertible Preferred Units in the Operating Partnership (“Series B Preferred Units”) to the Investor (as described in Note 10), the terms of which provide that the Investor may convert its preferred units into common units at its discretion. On an as-converted basis, as of September 30, 2016, the Investor owns 57.9% and we own the remaining interest in the Operating Partnership and the HC Operating Partnership, LP. We anticipate that we will conduct all or a portion of our operations through the Operating Partnership. Our financial statements and the financial statements of the Operating Partnership are consolidated in the accompanying condensed consolidated financial statements. All intercompany accounts and transactions have been eliminated in consolidation.
2. Summary of Significant Accounting Policies
For more information regarding our significant accounting policies and estimates, please refer to “Summary of Significant Accounting Policies” contained in our Annual Report on Form 10-K for the year ended December 31, 2015.
Principles of Consolidation and Basis of Presentation
The accompanying condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation. In accordance with the guidance for the consolidation of variable interest entities (“VIEs”), we analyze our variable interests, including investments in partnerships and joint ventures, to determine if the entity in which we have a variable interest is a variable interest entity. Our analysis includes both quantitative and qualitative reviews, based on our review of the design of the entity, its organizational structure including decision-making ability, risk and reward sharing experience and financial condition of other partner(s), voting rights, involvement in day-to-day capital and operating decisions and financial agreements. We also use quantitative and qualitative analyses to determine if we must consolidate a variable interest entity as the primary beneficiary.
Interim Financial Information
The accompanying interim condensed consolidated financial statements have been prepared by our management in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and in conjunction with the rules and regulations of the Securities and Exchange Commission (the “SEC”). Certain information and note disclosures required for annual financial statements have been condensed or excluded pursuant to SEC rules and regulations. Accordingly, the interim condensed consolidated financial statements do not include all of the information and notes required by GAAP for complete financial statements. The accompanying financial information reflects all adjustments which are, in the opinion of our management, of a normal recurring nature and necessary for a fair presentation of our financial position, results of operations and cash flows for the interim periods. Operating results for the three and nine months ended September 30, 2016 are not necessarily indicative of the results that may be expected for the year ending December 31, 2016. Our accompanying interim condensed consolidated financial statements should be read in conjunction with our audited condensed consolidated financial statements and the notes thereto included on our 2015 Annual Report on Form 10-K, as filed with the SEC.
Reclassifications
On January 1, 2016 we adopted Accounting Standards Update (“ASU”) 2015-03, “Simplifying the Presentation of Debt Issuance Costs,” which requires that debt issuance costs related to the Company’s recognized notes payable be presented in the balance sheet as a direct deduction from the carrying amount of the notes payable, consistent with debt discounts. The recognition and measurement guidance for debt issuance costs are not affected. The guidance requires retrospective adoption for all prior periods presented. As of September 30, 2016 and December 31, 2015, $4.1 million and $3.4 million, respectively have been reclassified from deferred financing costs to the related notes payable in the condensed consolidated balance sheets.
Recent Accounting Pronouncements
Adopted accounting standard
In February 2015, the Financial Accounting Standards Board (“FASB”) issued ASU 2015-02, “Amendments to the Consolidation Analysis,” which requires amendments to both the variable interest entity and voting models. The amendments (i) modify the identification of variable interests (fees paid to a decision maker or service provider), the VIE characteristics for a limited partnership or similar entity and primary beneficiary determination under the VIE model, and (ii) eliminate the presumption within the current voting model that a general partner controls a limited partnership or similar entity. The Company concluded that the Operating Partnership now meets the criteria as a VIE under ASU 2015-02 and the ASU was adopted as of January 1, 2016. The Company's significant asset is its investment in the Operating Partnership, as described in Note 1, and consequently, substantially all of the Company's assets and liabilities represent those assets and liabilities of the Operating Partnership. Accordingly, there is no change in the presentation of the condensed consolidated financial statements of the Company upon adoption of ASU 2015-02.
Pending accounting standards
In August 2016, the FASB issued ASU 2016-15, “Statement of Cash Flows (Topic 230)”, which indicated that there is diversity in practice in how certain cash receipts and cash payments are presented and classified in the statement of cash flows. ASU 2016-15 addresses eight specific cash flow issues with the objective of reducing the existing diversity in practice. This ASU is effective for annual reporting periods beginning after December 15, 2017, and interim periods within those fiscal years. Early adoption is permitted. Adoption of this ASU will not have a significant impact on our statement of cash flows.
In February 2016, the FASB issued ASU 2016-02, "Leases (Topic 842)", which amends various aspects of existing guidance for leases and requires additional disclosures about leasing arrangements. It will require companies to recognize lease assets and lease liabilities by lessees for those leases classified as operating leases under previous GAAP. This ASU retains a distinction between finance leases and operating leases. The classification criteria for distinguishing between finance leases and operating leases are substantially similar to the classification criteria for distinguishing between capital leases and operating leases in the previous leases guidance. The new guidance will be effective for the Company beginning on January 1, 2019 and earlier adoption is permitted. The Company is evaluating the impact of the adoption of the new guidance on its financial statements.
In 2014, the FASB issued ASU 2014-09, “Revenue from Contracts with Customers (Topic 606)”. The standard is a comprehensive new revenue recognition model that requires revenue to be recognized in a manner to depict the transfer of goods or services to a customer at an amount that reflects the consideration expected to be received in exchange for those goods or services. In 2015, the FASB provided for a one-year deferral of the effective date for ASU 2014-09 which is now effective for us beginning January 1, 2018. We are currently evaluating the impact that the standard will have on our condensed consolidated financial statements and have not yet determined the method by which we will adopt the standard.
7 |
3. Real Estate Note Receivable
On January 16, 2015, the Company, through indirect wholly owned subsidiaries, Sentio Georgetown, LLC and Sentio Georgetown TRS, LLC, originated a development loan in the amount of $41.9 million for the development of The Delaney at Georgetown Village located in Georgetown, Texas (the “Georgetown Loan”). The Georgetown Loan is secured by a first mortgage lien on the land, building, and all improvements made thereon. The Georgetown Loan matures on January 15, 2020 with one 12-month option to extend at the Company’s option, and bears interest at a fixed rate of 7.9% per annum for the term of the loan. At the maturity date, all unpaid principal, plus accrued and unpaid interest shall be due in full. Advances are made periodically during the construction period. The borrower paid a loan origination fee equal to 1% of the loan amount. Monthly payments are interest only for the term of the loan. The Company has the option to purchase the property at fair value at the earlier of stabilization or 48 months from the loan origination. Fair value is determined by the average asset value of independent appraisals obtained by the lender and borrower. Regardless of whether the Company exercises the option to purchase the property, the Company will be entitled to participate in the value creation which is the difference between the fair value and the total development cost. The Georgetown Loan is non-recourse to the borrowers, but one of the entities affiliated with the borrower has provided cost and completion guarantees as well as a guaranty of customary “bad boy” carve-outs.
Interest revenue on the loan receivable is recognized as earned based upon the principal amount outstanding subject to an evaluation of collectability risks. For the three and nine months ended September 30, 2016, interest revenue from the real estate note receivable was $0.6 million and $1.5 million, respectively. Interest revenue is recorded as a component of tenant reimbursements and other income in the condensed consolidated statement of operations. As of September 30, 2016, the borrower had made draws on the Georgetown Loan totaling $31.6 million, and the remaining commitment from the Company is approximately $10.3 million.
4. Investments in Real Estate
As of September 30, 2016, cost and accumulated depreciation and amortization related to real estate assets and related lease intangibles were as follows:
Land | Buildings and Improvements | Furniture, Fixtures and Vehicles | Construction in Progress | Intangible Lease Assets | ||||||||||||||||
Cost | $ | 47,196,000 | $ | 431,035,000 | $ | 19,389,000 | $ | 11,767,000 | $ | 28,737,000 | ||||||||||
Accumulated depreciation and amortization | - | (42,262,000 | ) | (7,499,000 | ) | - | (23,808,000 | ) | ||||||||||||
Net | $ | 47,196,000 | $ | 388,773,000 | $ | 11,890,000 | $ | 11,767,000 | $ | 4,929,000 |
As of December 31, 2015, cost and accumulated depreciation and amortization related to real estate assets and related lease intangibles were as follows:
Land | Buildings and Improvements | Furniture, Fixtures and Vehicles | Construction in Progress | Intangible Lease Assets | ||||||||||||||||
Cost | $ | 47,196,000 | $ | 429,945,000 | $ | 18,746,000 | $ | 5,168,000 | $ | 28,737,000 | ||||||||||
Accumulated depreciation and amortization | - | (32,711,000 | ) | (6,086,000 | ) | - | (22,006,000 | ) | ||||||||||||
Net | $ | 47,196,000 | $ | 397,234,000 | $ | 12,660,000 | $ | 5,168,000 | $ | 6,731,000 |
Depreciation expense associated with buildings and improvements and furniture, fixtures, and vehicles for the three months ended September 30, 2016 and 2015 was approximately $3.7 million and $3.6 million, respectively.
Depreciation expense associated with buildings and improvements and furniture, fixtures, and vehicles for the nine months ended September 30, 2016 and 2015 was approximately $11.0 million and $10.0 million, respectively.
Estimated amortization associated with intangible lease assets for October 1, 2016 through December 31, 2016 and each of the subsequent years is as follows:
Intangible Assets | ||||
October 1,2016 - December 31, 2016 | $ | 97,000 | ||
2017 | 388,000 | |||
2018 | 388,000 | |||
2019 | 295,000 | |||
2020 | 295,000 | |||
2021 and thereafter | 3,466,000 | |||
$ | 4,929,000 |
The estimated useful lives for intangible assets range from approximately two to 21 years. As of September 30, 2016, the weighted-average amortization period for intangible assets was 17 years.
5. Investments in Unconsolidated Entities
As of September 30, 2016, the Company owns interests in the following entities that are accounted for under the equity method of accounting:
Entity(1) | Property Type | Acquired | Investment(2) | Ownership % | ||||||||
Physicians Center MOB | Medical Office Building | April 2012 | $ | - | 71.9% | |||||||
Buffalo Crossings | Assisted-Living Facility | January 2014 | 567,000 | 25.0% | ||||||||
$ | 567,000 |
(1) | These entities are not consolidated because the Company exercises significant influence, but does not control or direct the activities that most significantly impact the entity’s performance. |
(2) | Represents the carrying value of the Company’s investment in the unconsolidated entities. |
Summarized combined financial information for the Company’s unconsolidated entities is as follows:
September 30, | December 31, | |||||||
2016 | 2015 | |||||||
Cash and cash equivalents | $ | 596,000 | $ | 279,000 | ||||
Investments in real estate, net | 22,911,000 | 24,712,000 | ||||||
Other assets | 750,000 | 713,000 | ||||||
Total assets | $ | 24,257,000 | $ | 25,704,000 | ||||
Notes payable, net | $ | 23,123,000 | $ | 22,679,000 | ||||
Accounts payable and accrued liabilities | 344,000 | 285,000 | ||||||
Other liabilities | 369,000 | 49,000 | ||||||
Total stockholders’ equity | 421,000 | 2,691,000 | ||||||
Total liabilities and equity | $ | 24,257,000 | $ | 25,704,000 |
8 |
Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||
2016 | 2015(1) | 2016 | 2015(1) | |||||||||||||
Total revenues | $ | 3,003,000 | $ | 803,000 | $ | 3,955,000 | $ | 1,791,000 | ||||||||
Net loss | (134,000 | ) | (306,000 | ) | (1,230,000 | ) | (729,000 | ) | ||||||||
Company’s equity in loss from unconsolidated entities | 35,000 | 86,000 | 163,000 | 259,000 |
(1) | On January 28, 2014, through a wholly-owned subsidiary, we acquired a 25% interest in a joint venture entity that has developed Buffalo Crossings, a 108-unit, assisted living community, which commenced operations in May 2015. |
6. Income Taxes
For federal income tax purposes, we have elected to be taxed as a real estate investment trust (“REIT”) under Sections 856 through 860 of the Internal Revenue Code of 1986, as amended (the “Code”), beginning with our taxable year ended December 31, 2008, which imposes limitations related to operating assisted-living properties. Generally, to qualify as a REIT, we cannot directly operate assisted-living facilities. However, such facilities may generally be operated by a taxable REIT subsidiary (“TRS”) pursuant to a lease with the Company. Therefore, we have formed Master HC TRS, LLC (“Master TRS”), a wholly owned subsidiary of HC Operating Partnership, LP, to lease any assisted-living properties we acquire and to operate the assisted-living properties pursuant to contracts with unaffiliated management companies. The Company made the applicable election for Master TRS to qualify as a TRS. Under the management contracts, the management companies have direct control of the daily operations of these assisted-living properties.
Each TRS is a tax paying component for purposes of classifying deferred tax assets and liabilities. We record net deferred tax assets to the extent we believe these assets will more likely than not be realized. In making such determination, we consider all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax planning strategies and recent financial operations. In the event we were to determine that we would not be able to realize our deferred income tax assets in the future in excess of their net recorded amount, we would establish a valuation allowance which would reduce the provision for income taxes.
The Master TRS recognized a $0.4 million benefit and a $0.9 million benefit for federal and state income taxes in the three months ended September 30, 2016 and 2015, respectively, and a $1.3 million benefit and a $2.6 million benefit for federal and state income taxes in the nine months ended September 30, 2016 and 2015, respectively. Net deferred tax assets related to the TRS entities totaled approximately $7.3 million at September 30, 2016 and $6.0 million at December 31, 2015, respectively, related primarily to book and tax basis differences for straight-line rent and accrued liabilities. At September 30, 2016, the Master TRS had net operating loss carryforwards for federal income tax purposes of approximately $2.3 million, which if unused, begin to expire in 2035. Realization of these deferred tax assets is dependent in part upon generating sufficient taxable income in future periods. Deferred tax assets are included in deferred costs and other assets in our condensed consolidated balance sheets. We have not recorded a valuation allowance against our deferred tax assets as of September 30, 2016, as we have determined that the future projected taxable income from the operations of the TRS entities are sufficient to recover the deferred tax assets.
7. Segment Reporting
As of September 30, 2016, we operated in three reportable business segments for management and internal financial reporting purposes: senior living operations, triple-net leased properties, and medical office building (“MOB”) properties. These operating segments are the segments of the Company for which separate financial information is available and for which segment results are evaluated regularly by the chief operating decision maker in deciding how to allocate resources and in assessing performance. Our senior living operations segment primarily consists of investments in senior housing communities located in the United States for which we engage independent third-party managers. Our triple-net leased properties segment consists of investments in senior living, skilled nursing and hospital facilities in the United States. These facilities are leased to healthcare operating companies under long-term “triple-net” or “absolute-net” leases, which require the tenants to pay all property-related expenses. Our MOB properties segment primarily consists of investing in medical office buildings and leasing those properties to healthcare providers under long-term leases, which may require tenants to pay property-related expenses.
We evaluate performance of the combined properties in each segment based on net operating income. Net operating income is defined as total revenue less property operating and maintenance expenses. There are no intersegment sales or transfers. We use net operating income to evaluate the operating performance of our real estate investments and to make decisions concerning the operation of the property. We believe that net operating income is useful to investors in understanding the value of income-producing real estate. Net income is the GAAP measure that is most directly comparable to net operating income; however, net operating income should not be considered as an alternative to net income as the primary indicator of operating performance as it excludes certain items such as depreciation and amortization, asset management fees, real estate acquisition costs, interest expense and corporate general and administrative expenses. Additionally, net operating income as we define it may not be comparable to net operating income as defined by other REITs or companies.
The following tables reconcile the segment activity to consolidated net loss for the three and nine months ended September 30, 2016 and 2015:
Three Months Ended September 30,2016 | Three Months Ended September 30 ,2015 | |||||||||||||||||||||||||||||||
Senior living operations | Triple-net leased properties | MOB Properties | Consolidated | Senior living operations | Triple-net leased properties | MOB Properties | Consolidated | |||||||||||||||||||||||||
Rental revenue | $ | 20,660,000 | $ | 2,299,000 | $ | 205,000 | $ | 23,164,000 | $ | 18,509,000 | $ | 2,328,000 | $ | 216,000 | $ | 21,053,000 | ||||||||||||||||
Resident services and fee income | 8,263,000 | - | - | 8,263,000 | 7,886,000 | - | - | 7,886,000 | ||||||||||||||||||||||||
Tenant reimbursements and other income | 818,000 | 246,000 | 78,000 | 1,142,000 | 457,000 | 301,000 | 78,000 | 836,000 | ||||||||||||||||||||||||
29,741,000 | 2,545,000 | 283,000 | 32,569,000 | 26,852,000 | 2,629,000 | 294,000 | 29,775,000 | |||||||||||||||||||||||||
Property operating and maintenance expenses | 20,546,000 | 250,000 | 83,000 | 20,879,000 | 19,193,000 | 319,000 | 83,000 | 19,595,000 | ||||||||||||||||||||||||
Net operating income | $ | 9,195,000 | $ | 2,295,000 | $ | 200,000 | $ | 11,690,000 | $ | 7,659,000 | $ | 2,310,000 | $ | 211,000 | $ | 10,180,000 | ||||||||||||||||
General and administrative | 373,000 | 383,000 | ||||||||||||||||||||||||||||||
Asset management fees | 527,000 | 1,581,000 | ||||||||||||||||||||||||||||||
Real estate acquisition costs | - | 111,000 | ||||||||||||||||||||||||||||||
Depreciation and amortization | 3,763,000 | 5,459,000 | ||||||||||||||||||||||||||||||
Interest expense, net | 4,169,000 | 3,571,000 | ||||||||||||||||||||||||||||||
Change in fair value of contingent consideration | (103,000 | ) | 402,000 | |||||||||||||||||||||||||||||
Equity in loss from unconsolidated entities | 35,000 | 86,000 | ||||||||||||||||||||||||||||||
Loss on debt extinguishment | 378,000 | - | ||||||||||||||||||||||||||||||
Income tax benefit | (410,000 | ) | (904,000 | ) | ||||||||||||||||||||||||||||
Net income (loss) | $ | 2,958,000 | $ | (509,000 | ) | |||||||||||||||||||||||||||
Preferred return to series B preferred OP units | ||||||||||||||||||||||||||||||||
and other noncontrolling interests | 3,010,000 | 2,447,000 | ||||||||||||||||||||||||||||||
Net loss attributable to common stockholders | $ | (52,000 | ) | $ | (2,956,000 | ) |
9 |
Nine Months Ended September 30, 2016 | Nine Months Ended September 30, 2015 | |||||||||||||||||||||||||||||||
Senior living operations | Triple-net leased properties | MOB Properties | Consolidated | Senior living operations | Triple-net leased properties | MOB Properties | Consolidated | |||||||||||||||||||||||||
Rental revenue | $ | 60,992,000 | $ | 6,301,000 | $ | 640,000 | $ | 67,933,000 | $ | 50,817,000 | $ | 6,986,000 | $ | 647,000 | $ | 58,450,000 | ||||||||||||||||
Resident services and fee income | 24,708,000 | - | - | 24,708,000 | 23,331,000 | - | 14,000 | 23,345,000 | ||||||||||||||||||||||||
Tenant reimbursements and other income | 2,225,000 | 2,064,000 | 234,000 | 4,523,000 | 1,125,000 | 917,000 | 220,000 | 2,262,000 | ||||||||||||||||||||||||
87,925,000 | 8,365,000 | 874,000 | 97,164,000 | 75,273,000 | 7,903,000 | 881,000 | 84,057,000 | |||||||||||||||||||||||||
Property operating and maintenance expenses | 60,723,000 | 929,000 | 275,000 | 61,927,000 | 53,265,000 | 921,000 | 245,000 | 54,431,000 | ||||||||||||||||||||||||
Net operating income | $ | 27,202,000 | $ | 7,436,000 | $ | 599,000 | $ | 35,237,000 | $ | 22,008,000 | $ | 6,982,000 | $ | 636,000 | $ | 29,626,000 | ||||||||||||||||
General and administrative | 1,475,000 | 2,086,000 | ||||||||||||||||||||||||||||||
Asset management fees | 3,200,000 | 4,495,000 | ||||||||||||||||||||||||||||||
Real estate acquisition costs | - | 1,461,000 | ||||||||||||||||||||||||||||||
Depreciation and amortization | 12,717,000 | 15,434,000 | ||||||||||||||||||||||||||||||
Interest expense, net | 11,801,000 | 10,258,000 | ||||||||||||||||||||||||||||||
Change in fair value of contingent consideration | 203,000 | 1,002,000 | ||||||||||||||||||||||||||||||
Equity in loss from unconsolidated entities | 163,000 | 259,000 | ||||||||||||||||||||||||||||||
Loss on debt extinguishment | 378,000 | - | ||||||||||||||||||||||||||||||
Income tax benefit | (1,310,000 | ) | (2,629,000 | ) | ||||||||||||||||||||||||||||
Net income (loss) | $ | 6,610,000 | $ | (2,740,000 | ) | |||||||||||||||||||||||||||
Preferred return to series B preferred OP units | ||||||||||||||||||||||||||||||||
and other noncontrolling interests | 8,627,000 | 6,630,000 | ||||||||||||||||||||||||||||||
Net loss attributable to common stockholders | $ | (2,017,000 | ) | $ | (9,370,000 | ) |
The following table reconciles the segment activity to consolidated financial position as of September 30, 2016 and December 31, 2015.
September 30, 2016 | December 31, 2015 | |||||||
Assets | ||||||||
Investment in real estate: | ||||||||
Senior living operations | $ | 398,443,000 | $ | 389,733,000 | ||||
Triple-net leased properties | 90,576,000 | 87,432,000 | ||||||
Medical office building properties | 7,116,000 | 7,251,000 | ||||||
Total reportable segments | $ | 496,135,000 | $ | 484,416,000 | ||||
Reconciliation to consolidated assets: | ||||||||
Cash and cash equivalents | 36,282,000 | 22,801,000 | ||||||
Investment in unconsolidated entities | 567,000 | 880,000 | ||||||
Tenant and other receivables, net | 5,490,000 | 5,751,000 | ||||||
Deferred costs and other assets | 9,965,000 | 8,636,000 | ||||||
Restricted cash | 6,405,000 | 6,748,000 | ||||||
Goodwill | 5,965,000 | 5,965,000 | ||||||
Total assets | $ | 560,809,000 | $ | 535,197,000 |
10 |
8. Fair Value Measurements
The FASB Accounting Standards Codification (“ASC”) 825-10, “Financial Instruments,” requires the disclosure of fair value information about financial instruments, whether or not recognized on the face of the balance sheet, for which it is practical to estimate that value.
Fair value represents the estimate of the proceeds to be received, or paid in the case of a liability, in a current transaction between willing parties. ASC 820, “Fair Value Measurement” establishes a fair value hierarchy to categorize the inputs used in valuation techniques to measure fair value. Inputs are either observable or unobservable in the marketplace. Observable inputs are based on market data from independent sources and unobservable inputs reflect the reporting entity’s assumptions about market participant assumptions used to value an asset or liability.
Our balance sheets include the following financial instruments: cash and cash equivalents, tenant and other receivables, net, deferred costs and other assets, restricted cash, notes payable, net, accounts payable and accrued liabilities, prepaid rent and security deposits and distributions payable. With the exception of notes payable and our contingent consideration discussed below, we consider the carrying values of our financial instruments to approximate fair value because they generally expose the Company to limited credit risk and because of the short period of time between origination of the financial assets and liabilities and their expected settlement.
As of September 30, 2016, the estimated fair value of the contingent consideration related to the Sumter Grand and Armbrook Village acquisitions is $8.7 million, which represents a change in fair value of ($0.1) million and $0.2 million for the three and nine month periods ended September 30, 2016, respectively. The change in fair value of contingent consideration is due to a change in the projected timing to achieve certain specified net operating income thresholds for the Sumter Grand and Armbrook Village properties. During the nine months ended September 30, 2016, the Company paid the entire Gables of Hudson earnout of $2.2 million and $1.8 million of the Armbrook Village earnout, as the first tier of the net operating income threshold was met in June 2016. The liabilities are included in accounts payable and accrued liabilities in our accompanying condensed consolidated balance sheets.
The fair value of the contingent consideration is based on significant inputs which are not observable to the market and as a result are classified in Level 3 of the fair value hierarchy. The fair value is derived by making assumptions on the timing of the lease up process based on actual performance as compared to internal underwriting models and applying a discount rate in the range of 9.0% to 12.0% to the actual liabilities to obtain a present value.
The fair value of the Company’s notes payable is estimated by discounting future cash flows of each instrument at rates that reflect the current market rates available to the Company for debt of the same terms and maturities. The fair value of the notes payable was determined using Level 2 inputs of the fair value hierarchy. Based on the estimates used by the Company, the fair value of notes payable was $356.2 million and $337.9 million, compared to the carrying values of $357.4 million ($353.2 million, net of discount and deferred financing costs) and $338.7 million ($335.3 million, net of discount and deferred financing costs) at September 30, 2016 and December 31, 2015, respectively.
There were no transfers between Level 1 or 2 during the three and nine months ended September 30, 2016.
9. Notes Payable
Notes payable were $357.4 million ($353.2 million, net of discount and deferred financing costs) and $338.7 million ($335.3 million, net of discount and deferred financing costs) as of September 30, 2016 and December 31, 2015, respectively. As of September 30, 2016, we had fixed and variable rate secured mortgage loans with effective interest rates ranging from 2.76% to 6.43% per annum and a weighted average effective interest rate of 4.19% per annum. As of September 30, 2016, notes payable consisted of $194.6 million of fixed rate debt, or approximately 54% of notes payable, at a weighted average interest rate of 4.74% per annum and $162.7 million of variable rate debt, or approximately 46% of notes payable, at a weighted average interest rate of 3.53% per annum. As of December 31, 2015, we had $179.0 million of fixed rate debt, or 53% of notes payable, at a weighted average interest rate of 4.78% per annum and $159.7 million of variable rate debt, or 47% of notes payable, at a weighted average interest rate of 3.17% per annum.
On August 19, 2016, we entered into three Multifamily Loan and Security Agreements (the “Loans”) with KeyBank National Association (“KeyBank”), an unaffiliated lender, originated under Fannie Mae’s Delegated Underwriting and Servicing Product Line for aggregate borrowings of approximately $54.6 million, to refinance our Spring Village at Wildewood, Gables of Hudson, and Sumter Place properties. The Loans bear interest at a variable rate of one-month LIBOR plus 2.66% for a term of 10 years. Loan payments are interest only for the first five years of the loan term, after which we will also be obligated to repay principal in specified fixed monthly amounts. All unpaid principal and accrued interest will be payable upon the maturity of each loan. The Loans are secured by the refinanced properties. We may prepay each Loan in full at any time (1) after September 1, 2017 and until May 31, 2026 upon payment of a prepayment premium equal to 1% of the principal amount prepaid, and (2) after May 31, 2026 with no prepayment premium. In connection with documentation and closing of the Loans, we paid fees and expenses totaling approximately $1.4 million.
On August 19, 2016, we entered into a Secured Loan Agreement with KeyBank, with an aggregate loan amount of approximately $62.1 million (the “Portfolio Loan”), of which approximately $57.0 million in principal is currently outstanding. The Portfolio Loan represents a refinancing and is secured by our Woodbury Mews, Sumter Grand, Mesa Vista Inn Health Center, Live Oaks Village of Hammond and Slidell properties. The Portfolio Loan has an initial term of three years with a one-year extension fee available upon payment of an extension equal to 0.25% of the loan amount. The Portfolio Loan bears interest at a rate of one-month LIBOR plus 3.0%. In connection with the closing of the Portfolio Loan, we paid fees and expenses of $1.1 million, including a commitment fee of approximately $698,000 to the lender. We may prepay the Portfolio Loan at any time, subject to certain conditions. Payments on the loans are due monthly and consist of accrued interest-only during the initial two years. Beginning in the third year, payments will consist of interest plus principal amortization payments based upon a 30-year amortization schedule. As a condition to obtaining the Portfolio Loan, we provided KeyBank with a limited guaranty of 30% of the outstanding loan amount.
In connection with the closing of the loans described above, the Company recognized a loss on debt extinguishment in the amount of $0.4 million, which is included in loss on debt extinguishment and other expense in the accompanying consolidated statements of operations.
On August 31, 2016, we entered into a Participation Agreement (the “Participation Agreement”) among Red Capital Partners, LLC (“Red Capital”), an unaffiliated lender, and Sentio Georgetown, LLC and Sentio Georgetown TRS, LLC, which are wholly owned subsidiaries of the Company. Pursuant to the Participation Agreement, Red Capital entered into a $20.0 million senior participation interest (the “Red Capital Loan”) in the Georgetown Loan (refer to Note 3). In connection with the closing of the Red Capital Loan, the Company paid a commitment fee of $200,000 to Red Capital. The Red Capital Loan bears interest at a rate of 5.25% and matures on January 15, 2020, which is coterminous with the Georgetown Loan. Loan payments are interest only for the full term of the Red Capital Loan. The Red Capital Loan has a one-year extension available upon payment of a fee equal to 0.5% of the Red Capital Loan amount. As of September 30, 2016, Red Capital has funded $9.7 million under the Red Capital Loan and plans to fund the remainder as the Company receives draw requests on the Georgetown Loan.
We are required by the terms of the applicable loan documents to meet certain financial covenants, such as debt service coverage ratios, rent coverage ratios and reporting requirements. As of September 30, 2016, we were in compliance with all such covenants and requirements.
Principal payments due on our notes payable for October 1, 2016 to December 31, 2016 and each of the subsequent years is as follows:
Year | Principal Amount | |||
October 1, 2016 - December 31, 2016 | $ | 741,000 | ||
2017 | 15,248,000 | |||
2018 | 28,168,000 | |||
2019 | 132,934,000 | |||
2020 | 47,019,000 | |||
2021 and thereafter | 133,247,000 | |||
$ | 357,357,000 | |||
Less: Deferred financing costs | 4,079,000 | |||
Less: Discount | 122,000 | |||
$ | 353,156,000 |
11 |
Interest Expense and Deferred Financing Cost
For the three months ended September 30, 2016 and 2015, the Company incurred interest expense, including amortization of deferred financing costs of $4.2 million and $3.6 million, respectively. For the nine months ended September 30, 2016 and 2015, the Company incurred interest expense, including amortization of deferred financing costs of $11.8 million and $10.3 million, respectively. As of September 30, 2016 and December 31, 2015, the Company’s net deferred financing costs were approximately $4.1 million and $3.4 million, respectively. All deferred financing costs are capitalized and amortized over the life of the respective loan agreement.
10. Stockholders’ Equity
Common Stock
Our charter authorizes the issuance of 580,000,000 shares of common stock with a par value of $0.01 per share and 20,000,000 shares of preferred stock with a par value of $0.01 per share, of which 1,000 shares are designated as Senior Cumulative Preferred Stock, Series C (the “Series C Preferred Stock”). As of September 30, 2016 and December 31, 2015, including distributions reinvested, we had issued approximately 13.4 million shares and 13.3 million shares of common stock for a total of approximately $133.5 million and $132.3 million of gross proceeds, respectively, in our public offerings.
Preferred Stock and OP Units
On February 10, 2013, we entered into a series of agreements, which have been amended at various points after February 10, 2013, with Sentinel RE Investment Holdings LP (the “Investor”), an affiliate of Kohlberg Kravis Roberts & Co. L.P. (together with its affiliates, “KKR”) for the purpose of obtaining equity funding to finance investment opportunities (such investment and the related agreements, as amended, are referred to herein collectively as the “KKR Equity Commitment”). Pursuant to the KKR Equity Commitment, we could issue and sell to the Investor and its affiliates on a private placement basis from time to time over a period of up to three years, up to $158.7 million in aggregate issuance amount of preferred securities in the Company and the Operating Partnership. At September 30, 2016, no securities remain issuable under the KKR Equity Commitment.
As of September 30, 2016 and December 31, 2015 we had issued 1,000 shares of Series C Preferred Stock and 1,586,000 Series B Preferred Units to the Investor for a total commitment of $158.7 million, respectively. As of September 30, 2016, the Company has received $156.3 million of the total commitment and $2.3 million of equity remains to be funded under the KKR Equity Commitment which will be drawn by the Company to fund the Georgetown Loan. For the three and nine months ended September 30, 2016, the Company received $3.9 million and $18.3 million of proceeds from KKR related to previously issued Series B Preferred Units. The Series B Preferred Units outstanding are classified within noncontrolling interests and are convertible into approximately 15,830,938 shares of the Company’s common stock, as of September 30, 2016 and December 31, 2015.
The Series C Preferred Stock ranks senior to the Company’s common stock with respect to dividend rights and rights on liquidation. The holders of the Series C Preferred Stock are entitled to receive dividends, as and if authorized by our board of directors out of funds legally available for that purpose, at an annual rate equal to 3% of the liquidation preference for each share. Dividends on the Series C Preferred Stock are payable annually in arrears.
The Series B Preferred Units rank senior to the Operating Partnership’s common units with respect to distribution rights and rights on liquidation. With the exception of certain Series B Preferred Units issued in connection with the put exercise related to the Georgetown Loan (the “Georgetown Put”), the Series B Preferred Units are entitled to receive cash distributions at an annual rate equal to 7.5% of the Series B liquidation preference in preference to any distributions paid to common units. In December 2014, the parties amended the Second Amended and Restated Limited Partnership Agreement (the “Partnership Agreement”) to provide that the Series B Preferred Units issued in connection with the Georgetown Put would receive cash distributions at a reduced annual rate equal to 6.0%. In addition, the preferred return for the Series B Preferred Units issued in connection with the Georgetown Put would be calculated based solely on the exercise put amount that has been funded. Effective August 31, 2016, the parties further amended the Partnership Agreement to provide that 219,120 Series B Preferred Units issued in connection with the Georgetown Put would continue receiving cash distributions at an annual rate of 6.0% and the remaining 200,000 Series B Preferred Units issued in connection with the Georgetown Put will receive cash distributions at an annual rate of 7.5%. If the Operating Partnership is unable to pay cash distributions, distributions will be paid in kind at an annual rate of 10.0% of the Series B liquidation preference.
After payment of the preferred distributions, additional distributions will be paid first to the common units until they have received an aggregate blended return equal to a weighted average interest rate determined taking into account the Series B Preferred Units receiving a 6.0% return and the Series B Preferred Units receiving a 7.5% return per unit in annual distributions commencing from February 10, 2013, and thereafter to the common units and Series B Preferred Units pro rata.
For the three and nine months ended September 30, 2016, the Operating Partnership paid distributions on the Series B Preferred Units in the amount of $2.8 million and $8.1 million, respectively. For the three and nine months ended September 30, 2015, the Operating Partnership paid distributions on the Series B Preferred Units in the amount of $2.4 million and $7.8 million, respectively.
Distributions Available to Common Stockholders
The following are the distributions declared on our common stock during the nine months ended September 30, 2016 and 2015:
Distributions Declared(1)(2) | Cash Flow from | |||||||||||||||
Period | Cash | Reinvested | Total | Operations | ||||||||||||
First quarter 2015 | $ | 1,330,000 | $ | 85,000 | $ | 1,415,000 | $ | 3,348,000 | ||||||||
Second quarter 2015 | 1,347,000 | 85,000 | 1,432,000 | 4,369,000 | ||||||||||||
Third quarter 2015 | 1,363,000 | 86,000 | 1,449,000 | 5,515,000 | ||||||||||||
$ | 4,040,000 | $ | 256,000 | $ | 4,296,000 | $ | 13,232,000 | |||||||||
First quarter 2016 | $ | 1,342,000 | $ | 89,000 | $ | 1,431,000 | $ | 6,871,000 | ||||||||
Second quarter 2016 | 1,343,000 | 88,000 | 1,431,000 | 4,607,000 | ||||||||||||
Third quarter 2016 | 1,358,000 | 91,000 | 1,449,000 | 7,072,000 | ||||||||||||
$ | 4,043,000 | $ | 268,000 | $ | 4,311,000 | $ | 18,550,000 |
(1) | In order to meet the requirements for being treated as a REIT under the Internal Revenue Code, we must pay distributions to our stockholders each taxable year equal to least 90% of our net ordinary taxable income. |
(2) | This table represents distributions declared to common stockholders for each respective period. These amounts do not include distribution payments to the Series B Preferred Unit holders for the three and nine months ended September 30, 2016 and 2015. |
Commencing with the declaration of distributions for daily record dates occurring in the second quarter of 2013 and thereafter, our board of directors has declared distributions on our common stock in amounts per share that, if declared and paid each day for a 365-day period, would equate to an annualized rate of $0.50 per share (5.00% based on the initial purchase price of our common stock of $10.00).
In connection with the Participation Agreement (as described in Note 9), the Board of Directors adopted a Regular Quarterly Dividend Policy (the “Dividend Policy”), which documents the circumstances under which the Board of Directors may increase the regular quarterly dividend that may be paid to holders of the common stock of the Company (the “Regular Quarterly Dividend Rate”) from its current level of $0.125 per share without the consent of the Investor. The Dividend Policy provides that the Company may maintain the Regular Quarterly Dividend Rate at the current level and that the Company may also elect to reduce the Regular Quarterly Dividend Rate in its discretion. The policy expires on August 31, 2019.
The declaration of distributions is at the discretion of our board of directors and our board will determine the amount of distributions on a regular basis. The amount of distributions will depend on our funds from operations, financial condition, capital requirements, annual distribution requirements under the REIT provisions of the Internal Revenue Code and other factors our board of directors deems relevant.
11. Earnings Per Share
We report earnings (loss) per share pursuant to ASC Topic 260, “Earningsper Share.” Basic earnings (loss) per share attributable for all periods presented are computed by dividing net income (loss) attributable to common stockholders by the weighted average number of shares of our common stock outstanding during the period. Diluted net earnings (loss) per common share attributable to common stockholders are computed based on the weighted average number of shares of our common stock and all potentially dilutive securities, if any. The Series B Preferred Units give rise to potentially dilutive securities of our common stock. As of September 30, 2016 there were 1,586,000 Series B Preferred Units outstanding, but such units were excluded from the computation of diluted earnings per share because such shares were anti-dilutive during these periods.
12 |
12. Related Party Transactions
Advisory Relationship with the Advisor
We have been party to an Advisory Agreement with the Advisor since January 1, 2012. The Advisory Agreement has been renewed since 2012 for additional one-year terms commencing on January 1, 2013, January 1, 2014, January 1, 2015, and January 1, 2016. Certain provisions of the Advisory Agreement were amended as a result of the execution on February 10, 2013 of a Transition to Internal Management Agreement which was subsequently amended in April 2014 and February 2015 (as amended, the “Transition Agreement”) with the Advisor.
Pursuant to the provisions of the Advisory Agreement, the Advisor is responsible for managing, operating, directing and supervising the operation of our company and its assets. Generally, the Advisor is responsible for providing us with (i) property acquisition, disposition and financing services, (ii) asset management and operational services, including real estate services and financial and administrative services, (iii) stockholder services, and (iv) in the event we conduct a public offering of our securities, offering-related services. The Advisor is subject to the supervision and ultimate authority of our board of directors and has a fiduciary duty to us and our stockholders.
The Advisory Agreement with our Advisor and the terms of the Transition Agreement are more fully described in our Annual Report on Form 10-K for the year ended December 31, 2015.
The fees payable to the Advisor under the Advisory Agreement for the three and nine months ended September 30, 2016 and September 30, 2015 were as follows:
Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||
2016 | 2015 | 2016 | 2015 | |||||||||||||
Asset Management Fees | $ | 527,000 | $ | 1,581,000 | $ | 3,200,000 | $ | 4,495,000 |
The Transition Agreement limits the amount of the fees payable under our existing Advisory Agreement with the Advisor. Specifically, notwithstanding the provisions of the Advisory Agreement, acquisition fees, financing coordination fees, asset management fees, property management and leasing fees, and disposition fees payable under the Advisory Agreement are limited to an amount no more than (1) $3.2 million plus an excess amount of $3.2 million (the “Excess Fee Amount”) from February 10, 2013 to February 10, 2014, and (2) $3.2 million plus any remaining portion of the Excess Fee Amount during the period from the February 11, 2014 to February 10, 2015. The maximum aggregate amount of such fees payable to the Advisor from February 10, 2013 through February 10, 2015 under these limits was $9.6 million (the “Maximum Fee Amount”). Solely with respect to any fees earned by the Advisor during the period from February 11, 2014 to February 10, 2015 in excess of the Maximum Fee Amount, such fees will be included in fees payable during the one-year period from February 11, 2015 to February 10, 2016, subject to a maximum amount of $1.0 million. For the one-year period from February 11, 2015 to February 10, 2016, as well as for the one-year period from February 11, 2016 to February 10, 2017, the same limits will apply to the aggregate fees the Advisor can earn such that the aggregate amount of such fees payable to the Advisor from February 11, 2015 to February 10, 2017 is equal to the Maximum Fee Amount. As of November 2015, the “Maximum Fee Amount” that could be earned from February 10, 2013 to February 10, 2015 of $9.6 million had been met, and as of July 2016 the “Maximum Fee Amount” that could be earned from February 10, 2016 to February 10, 2017 of $3.2 million had been met.
KKR Equity Commitment
Pursuant to the KKR Equity Commitment, we could issue and sell to the Investor and its affiliates on a private placement basis from time to time over a period of three years, up to $158.7 million in aggregate issuance amount of shares of newly issued Series C Preferred Stock and newly issued Series B Preferred Units to fund real estate acquisitions, a self-tender offer and the origination of a development loan. As a result of the transactions contemplated by the KKR Equity Commitment, the Investor currently beneficially owns an aggregate of 15,830,938 shares of common stock of the Company, which represents, in the aggregate, approximately 57.9% of the outstanding shares of common stock as of September 30, 2016.
As of September 30, 2016, pursuant to the terms of the KKR Equity Commitment, the Investor had purchased 1,000 newly issued Series C Preferred Stock and 1,586,000 newly issued Series B Preferred Units for an aggregate purchase price of $158.7 million. As of September 30, 2016 no Series B Preferred Units remain issuable under the KKR Equity Commitment.
The terms of the KKR Equity Commitment are more fully described in our Annual Report on Form 10-K for the year ended December 31, 2015.
13. Commitments and Contingencies
We monitor our properties for the presence of hazardous or toxic substances. While there can be no assurance that a material environmental liability does not exist, we are not currently aware of any environmental liability with respect to the properties that we believe would have a material effect on our financial condition, results of operations and cash flows. Further, we are not aware of any environmental liability or any unasserted claim or assessment with respect to an environmental liability that we believe would require additional disclosure or the recording of a loss contingency.
Our commitments and contingencies include the usual obligations of real estate owners and operators in the normal course of business. In the opinion of management, these matters are not expected to have a material impact on our condensed consolidated financial position, cash flows and results of operations. We are not presently subject to any material litigation nor, to our knowledge, is any material litigation threatened against the Company which if determined unfavorably to us would have a material adverse effect on our cash flows, financial condition or results of operations.
Refer to Note 3 “Real Estate Note Receivable” for additional information on the remaining commitment to fund our real estate note receivable.
Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations |
The following “Management’s Discussion and Analysis of Financial Condition and Results of Operations” should be read in conjunction with our financial statements and notes thereto contained elsewhere in this report. This section contains forward-looking statements, including estimates, projections, statements relating to our business plans, objectives and expected operating results, and the assumptions upon which those statements are based. These forward-looking statements generally are identified by the words “believes,” “project,” “expects,” “anticipates,” “estimates,” “intends,” “strategy,” “plan,” “may,” “will,” “would,” “will be,” “will continue,” “will likely result,” and similar expressions. Forward-looking statements are based on current expectations and assumptions that are subject to risks and uncertainties which may cause actual results to differ materially from the forward-looking statements. Forward-looking statements that were true at the time made may ultimately prove to be incorrect or false. We undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise. All forward-looking statements should be read in light of the risks identified in Part I, Item 1A of our annual report on Form 10-K for the year ended December 31, 2015 as filed with the SEC.
Our actual future results and trends may differ materially from expectations depending on a variety of factors discussed in our filings with the SEC. These factors include without limitation:
• | Changes in international, national and local economic conditions in the real estate and healthcare markets specifically and in the broader financial markets; |
• | legislative and regulatory changes impacting the healthcare industry, including the implementation of the healthcare reform legislation enacted in 2010; |
• | legislative and regulatory changes impacting real estate investment trusts, or REITs, including their taxation; |
13 |
• | volatility or uncertainty in capital markets, including the availability of debt and equity capital; |
• | changes in interest rates; |
• | competition in the real estate industry; |
• | the supply and demand for operating properties in our market areas; and |
• | changes in accounting principles generally accepted in the United States of America, or GAAP. |
Overview
We were incorporated on October 16, 2006 for the purpose of engaging in the business of investing in and owning commercial real estate and real estate-related assets. We intend to invest primarily in healthcare properties and other real estate-related assets related to healthcare located in markets in the United States.
Our business has been managed by an external advisor since the commencement of our initial public offering in June 2008 and we have no employees. Since January 1, 2012, our Advisor has managed our business pursuant to the Advisory Agreement. Subject to certain restrictions and limitations, the Advisor is responsible for conducting our operations and managing our portfolio of real estate and real estate-related assets. In addition, to the extent we make additional investments, the Advisor is responsible for identifying and making acquisitions and investments on our behalf. Our Advisor has contractual and fiduciary responsibilities to us and our stockholders.
On February 10, 2013, we entered into the KKR Equity Commitment for the purpose of obtaining equity funding to finance investment opportunities. Pursuant to the KKR Equity Commitment, we could issue and sell to the Investor and its affiliates on a private placement basis from time to time over a period of up to three years, up to $158.7 million in aggregate issuance amount of preferred securities in the Company and the Operating Partnership. No securities remain issuable under the KKR Equity Commitment.
As of September 30, 2016, we had issued and outstanding 11,524,370 shares of common stock, and 1,000 shares of Series C Preferred Stock. All 1,000 shares of the Series C Preferred Stock were issued to the Investor pursuant to the KKR Equity Commitment. In addition, as of September 30, 2016 the Operating Partnership had issued and outstanding 11,544,370 Common Units, 1,000 Series A Preferred Units, and 1,586,000 Series B Preferred Units.
In connection with the KKR Equity Commitment, we entered into the Transition Agreement with our Advisor and the Investor which sets forth the terms for a transition to an internal management structure for the Company. The Transition Agreement requires that, unless the parties agree otherwise, the existing external advisory structure will remain in place upon substantially the same terms as currently in effect until February 10, 2017, upon which time the advisory function may be internalized in accordance with procedures set forth in the Transition Agreement.
We commenced an initial public offering of our common stock on June 20, 2008. We stopped making offers under the initial public offering on February 3, 2011 after raising gross offering proceeds of $123.9 million from the sale of approximately 12.4 million shares, including shares sold under the distribution reinvestment plan. On February 4, 2011, we commenced a follow-on offering of our common stock. We suspended primary offering sales in our follow-on offering on April 29, 2011 and completed the final sale of shares under the distribution reinvestment plan on May 10, 2011. We raised gross offering proceeds under the follow-on offering of $8.4 million from the sale of approximately 800,000 shares, including shares sold under the distribution reinvestment plan. On June 12, 2013, we deregistered all remaining unsold follow-on offering shares.
On June 19, 2013, we filed a registration statement on Form S-3 to register up to $99,000,000 of shares of common stock to be offered to our existing stockholders pursuant to the distribution reinvestment plan (the “DRIP Offering”). The purchase price for shares offered pursuant to the DRIP Offering is equal to the most recently announced estimated per-share value, as of the date the shares are purchased under the distribution reinvestment plan. The DRIP Offering shares were initially offered at a purchase price of $10.02; effective February 28, 2014, DRIP Offering shares were offered at a purchase price of $11.63 per share; and effective March 23, 2016 DRIP Offering shares are being offered at $12.45, which is our most recent estimated per-share value.
Our revenues, which are comprised largely of rental income, include rents reported on a straight-line basis over the initial term of each lease. Our growth depends, in part, on our ability to (i) increase rental income and other earned income from leases by increasing rental rates and occupancy levels; and (ii) control operating and other expenses, including maximizing tenant recoveries as provided for in lease structures. Our operations are impacted by property specific, market specific, general economic and other conditions.
Critical Accounting Policies
There have been no material changes to our critical accounting policies as previously disclosed in our Annual Report on Form 10-K for the year ended December 31, 2015, as filed with the SEC.
Results of Operations
As of September 30, 2016, we operated in three reportable business segments: senior living operations, triple-net leased properties, and medical office building (“MOB”) properties. Our senior living operations segment invests in and directs the operations of independent living, assisted-living, memory care and other senior housing communities located in the United States. We engage independent third party managers to operate these properties. Our triple-net leased properties segment invests in healthcare properties in the United States leased under long-term “triple-net” or “absolute-net” leases, which require the tenants to pay all property-related expenses. Our MOB segment invests in medical office buildings and leases those properties to healthcare providers under long-term “full service” leases which may require tenants to reimburse property related expenses to us.
As of September 30, 2016, we owned or had joint venture interests in 34 properties. These properties included 26 memory care, assisted-and independent-living facilities, which comprise our senior housing segment, one medical office building, which comprises our MOB segment, four operating healthcare facilities, which comprise our triple-net leased segment, one in-development facility, and two facilities held as unconsolidated entities. As of September 30, 2015, we owned or had joint venture interests in 34 properties. These properties included 25 memory care, assisted-and independent-living facilities, which comprise our senior housing segment, one medical office building, which comprises our MOB segment, four operating healthcare facilities, which comprise our triple-net leased segment, two in-development facilities, and two facilities held as unconsolidated entities. Sumter Grand was acquired in the first quarter of 2015, and Gables of Kentridge and Armbrook Village were acquired in the second quarter of 2015. Each of these properties are included in our senior living operations segment. We had no acquisition activity during 2016. The results of our operations for the three and nine months ended September 30, 2016 and 2015 vary largely as a result of acquisition activity.
14 |
Comparison of the Three Months Ended September 30, 2016 and 2015
Three Months Ended September 30, | ||||||||||||||||
2016 | 2015 | $ Change | % Change | |||||||||||||
Net operating income, as defined(1) | ||||||||||||||||
Senior living operations | $ | 9,195,000 | $ | 7,659,000 | $ | 1,536,000 | 20 | % | ||||||||
Triple-net leased properties | 2,295,000 | 2,310,000 | (15,000 | ) | (1 | )% | ||||||||||
Medical office building properties | 200,000 | 211,000 | (11,000 | ) | (5 | )% | ||||||||||
Total portfolio net operating income | $ | 11,690,000 | $ | 10,180,000 | $ | 1,510,000 | 15 | % | ||||||||
Reconciliation to net income (loss): | ||||||||||||||||
Net operating income, as defined(1) | $ | 11,690,000 | $ | 10,180,000 | $ | 1,510,000 | 15 | % | ||||||||
Other (income) expense: | ||||||||||||||||
General and administrative | 373,000 | 383,000 | (10,000 | ) | (3 | )% | ||||||||||
Asset management fees | 527,000 | 1,581,000 | (1,054,000 | ) | (67 | )% | ||||||||||
Real estate acquisition costs | - | 111,000 | (111,000 | ) | (100 | )% | ||||||||||
Depreciation and amortization | 3,763,000 | 5,459,000 | (1,696,000 | ) | (31 | )% | ||||||||||
Interest expense, net | 4,169,000 | 3,571,000 | 598,000 | 17 | % | |||||||||||
Change in fair value of contingent consideration | (103,000 | ) | 402,000 | (505,000 | ) | (126 | )% | |||||||||
Equity in loss from unconsolidated entities | 35,000 | 86,000 | (51,000 | ) | (59 | )% | ||||||||||
Loss on debt extinguishment | 378,000 | - | 378,000 | 100 | % | |||||||||||
Income tax benefit | (410,000 | ) | (904,000 | ) | 494,000 | (55 | )% | |||||||||
Net income (loss) | $ | 2,958,000 | $ | (509,000 | ) | $ | 3,467,000 | (681 | )% |
(1) | Net operating income, a non-GAAP supplemental measure, is defined as total revenue less property operating and maintenance expenses. We use net operating income to evaluate the operating performance of our consolidated real estate investments and to make decisions concerning the operation of the property. We believe that net operating income is useful to investors in understanding the value of our consolidated income-producing real estate. Net income is the GAAP measure that is most directly comparable to net operating income; however, net operating income should not be considered as an alternative to net income as the primary indicator of operating performance as it excludes certain items such as a gain or loss from investments in unconsolidated entities depreciation and amortization, interest expense and corporate general and administrative expenses. Additionally, net operating income as we define it may not be comparable to net operating income as defined by other REITs or companies. |
Senior Living Operations
Total revenue for senior living operations includes rental revenue and resident fees and service income. Property operating and maintenance expenses include labor, food, utilities, marketing, management and other property operating costs. Net operating income for the three months ended September 30, 2016 increased to $9.2 million from $7.7 million primarily as a result of the net operating income generated at The Parkway, which began operations in the third quarter of 2015. Additionally, interest revenue from the Georgetown Loan increased tenant reimbursement and other income due to additional draws by the borrower.
Three Months Ended September 30, | ||||||||||||||||
2016 | 2015 | $ Change | % Change | |||||||||||||
Senior Living Operations — Net operating income | ||||||||||||||||
Rental revenue | $ | 20,660,000 | $ | 18,509,000 | $ | 2,151,000 | 12 | % | ||||||||
Resident services and fee income | 8,263,000 | 7,886,000 | 377,000 | 5 | % | |||||||||||
Tenant reimbursement and other income | 818,000 | 457,000 | 361,000 | 79 | % | |||||||||||
Less: | ||||||||||||||||
Property operating and maintenance expenses | 20,546,000 | 19,193,000 | 1,353,000 | 7 | % | |||||||||||
Total portfolio net operating income | $ | 9,195,000 | $ | 7,659,000 | $ | 1,536,000 | 20 | % |
Triple-Net Leased Properties
Total revenue for triple-net leased properties includes rental revenue and expense reimbursements from tenants. Property operating and maintenance expenses include insurance and property taxes and other operating expenses reimbursed by our tenants. Net operating income for the three months ended September 30, 2016 of $2.3 million was comparable to the net operating income for the three months ended September 30, 2015.
Three Months Ended September 30, | ||||||||||||||||
2016 | 2015 | $ Change | % Change | |||||||||||||
Triple-Net Leased Properties — Net operating income | ||||||||||||||||
Rental revenue | $ | 2,299,000 | $ | 2,328,000 | $ | (29,000 | ) | (1 | )% | |||||||
Tenant reimbursement and other income | $ | 246,000 | 301,000 | (55,000 | ) | (18 | )% | |||||||||
Less: | ||||||||||||||||
Property operating and maintenance expenses | $ | 250,000 | 319,000 | (69,000 | ) | (22 | )% | |||||||||
Total portfolio net operating income | $ | 2,295,000 | $ | 2,310,000 | $ | (15,000 | ) | (1 | )% |
Medical Office Building Properties
Total revenue for medical office building properties includes rental revenue and expense reimbursements from tenants. Property operating and maintenance expenses include utilities, repairs and maintenance, insurance and property taxes. Net operating income for the three months ended September 30, 2016 of $0.2 million was comparable to net operating income for the three-month period ended September 30, 2015
Three Months Ended September 30, | ||||||||||||||||
2016 | 2015 | $ Change | % Change | |||||||||||||
Medical Office Building Properties — Net operating income | ||||||||||||||||
Rental revenue | $ | 205,000 | $ | 216,000 | $ | (11,000 | ) | (5 | )% | |||||||
Tenant reimbursement and other income | 78,000 | 78,000 | - | 0 | % | |||||||||||
Less: | ||||||||||||||||
Property operating and maintenance expenses | 83,000 | 83,000 | - | 0 | % | |||||||||||
Total portfolio net operating income | $ | 200,000 | $ | 211,000 | $ | (11,000 | ) | (5 | )% |
Unallocated (expenses) income
General and administrative expenses for the three months ended September 30, 2016 of $0.4 million was comparable to general and administrative expenses for the three months ended September 30, 2015.
Asset management fees for the three months ended September 30, 2016 decreased to $0.5 million from $1.6 million for the three months ended September 30, 2015 as a result of the advisor achieving the maximum fee amount for the period of February 11, 2016 through February 10, 2017 during the period ended September 30, 2016.
15 |
Real estate acquisition costs for the three months ended September 30, 2016 decreased to $0.0 million from $0.1 million for the three months ended September 30, 2015 as a result of no acquisition activity for the three months ended September 30, 2016.
Depreciation and amortization for the three months ended September 30, 2016 decreased to $3.8 million from $5.5 million for the three months ended September 30, 2015 due to higher depreciation and amortization in 2015 resulting from acquisitions, particularly amortization of the in-place leases for senior living facilities acquired in the fourth quarter of 2014 and the first and second quarters of 2015. These assets are generally amortized in the first twelve months after closing.
Interest expense, net, for the three months ended September 30, 2016 increased to $4.2 million from $3.6 million for the three months ended September 30, 2015 primarily as a result of the debt incurred for acquisitions that occurred in the first and second quarters of 2015 and the consolidation of The Parkway, which began operations in the third quarter of 2015.
The change in fair value of contingent consideration decreased to ($0.1) million for the three months ended September 30, 2016 from $0.4 million for the three months ended September 30, 2015 due to a change in the projected timing to achieve certain specified net operating income thresholds for the Sumter Grand and Armbrook Village properties. During the three months ended September 30, 2016, the Company paid $1.8 million of the Armbrook Village earnout, as the first tier of the net operating income threshold was met in June 2016.
The Company recognized a loss on debt extinguishment in the amount of $0.4 million for the three months ended September 30, 2016, as a result of the refinancing of the secured loan agreements with KeyBank for Mesa Vista Inn Health Center, Live Oaks of Hammond, Live Oaks of Slidell, Spring Village at Wildewood, Gables of Hudson, Sumter Place, Sumter Grand and Woodbury Mews.
The Company recognized a loss from unconsolidated entities of $0.1 million for the three months ended September 30, 2016, which was comparable to the loss recognized for three months ended September 30, 2015. The Company’s allocation of loss from unconsolidated entities relates to the operations of Buffalo Crossings and Physicians Center MOB.
During the three months ended September 30, 2016 and 2015, we recognized state and federal income tax benefit of approximately $0.4 million and $0.9 million, respectively, related to the operations of our senior living properties that were consolidated into our Master TRS. The decrease relates to the lower amortization of in-place lease value associated with properties acquired in late 2014 and early 2015.
Comparison of the Nine Months Ended September 30, 2016 and 2015
Nine Months Ended September 30, | ||||||||||||||||
2016 | 2015 | $ Change | % Change | |||||||||||||
Net operating income, as defined(1) | ||||||||||||||||
Senior living operations | $ | 27,202,000 | $ | 22,008,000 | $ | 5,194,000 | 24 | % | ||||||||
Triple-net leased properties | 7,436,000 | 6,982,000 | 454,000 | 7 | % | |||||||||||
Medical office building properties | 599,000 | 636,000 | (37,000 | ) | (6 | )% | ||||||||||
Total portfolio net operating income | $ | 35,237,000 | $ | 29,626,000 | 5,611,000 | 19 | % | |||||||||
Reconciliation to net income (loss): | ||||||||||||||||
Net operating income, as defined(1) | $ | 35,237,000 | $ | 29,626,000 | 5,611,000 | 19 | % | |||||||||
Other (income) expense: | ||||||||||||||||
General and administrative | 1,475,000 | 2,086,000 | (611,000 | ) | (29 | )% | ||||||||||
Asset management fees | 3,200,000 | 4,495,000 | (1,295,000 | ) | (29 | )% | ||||||||||
Real estate acquisitions costs | - | 1,461,000 | (1,461,000 | ) | (100 | )% | ||||||||||
Depreciation and amortization | 12,717,000 | 15,434,000 | (2,717,000 | ) | (18 | )% | ||||||||||
Interest expense, net | 11,801,000 | 10,258,000 | 1,543,000 | 15 | % | |||||||||||
Change in fair value of contingent consideration | 203,000 | 1,002,000 | (799,000 | ) | (80 | )% | ||||||||||
Equity in loss from unconsolidated entities | 163,000 | 259,000 | (96,000 | ) | (37 | )% | ||||||||||
Loss on debt extinguishment | 378,000 | - | 378,000 | 100 | % | |||||||||||
Income tax benefit | (1,310,000 | ) | (2,629,000 | ) | 1,319,000 | (50 | )% | |||||||||
Net income (loss) | $ | 6,610,000 | $ | (2,740,000 | ) | $ | 9,350,000 | (345 | )% |
(1) | Net operating income, a non-GAAP supplemental measure, is defined as total revenue less property operating and maintenance expenses. We use net operating income to evaluate the operating performance of our consolidated real estate investments and to make decisions concerning the operation of the property. We believe that net operating income is useful to investors in understanding the value of our consolidated income-producing real estate. Net income is the GAAP measure that is most directly comparable to net operating income; however, net operating income should not be considered as an alternative to net income as the primary indicator of operating performance as it excludes certain items such as a gain or loss from investments in unconsolidated entities depreciation and amortization, interest expense and corporate general and administrative expenses. Additionally, net operating income as we define it may not be comparable to net operating income as defined by other REITs or companies. |
Senior Living Operations
Total revenue for senior living operations includes rental revenue and resident fees and service income. Property operating and maintenance expenses include labor, food, utilities, marketing, management and other property operating costs. Net operating income for the nine months ended September 30, 2016 increased to $27.2 million from $22.0 million for the nine months ended September 30, 2015. The increase is primarily due to the acquisitions of Sumter Grand, Gables of Kentridge, and Armbrook Village in the first and second quarters of 2015 and the opening of The Parkway in the third quarter of 2015. The increase also reflects charges for higher levels of care at several senior living properties in the portfolio.
Nine Months Ended September 30, | ||||||||||||||||
2016 | 2015 | $ Change | % Change | |||||||||||||
Senior Living Operations — Net operating income | ||||||||||||||||
Rental revenue | $ | 60,992,000 | $ | 50,817,000 | $ | 10,175,000 | 20 | % | ||||||||
Resident services and fee income | 24,708,000 | 23,331,000 | 1,377,000 | 6 | % | |||||||||||
Tenant reimbursement and other income | 2,225,000 | 1,125,000 | 1,100,000 | 98 | % | |||||||||||
Less: | ||||||||||||||||
Property operating and maintenance expenses | 60,723,000 | 53,265,000 | 7,458,000 | 14 | % | |||||||||||
Total portfolio net operating income | $ | 27,202,000 | $ | 22,008,000 | $ | 5,194,000 | 24 | % |
Triple-Net Leased Properties
Total revenue for triple-net leased properties includes rental revenue and expense reimbursements from tenants. Property operating and maintenance expenses include insurance and property taxes and other operating expenses reimbursed by our tenants. Net operating income for the nine months ended September 30, 2016 increased to $7.4 million from $7.0 million primarily as a result of a $1.3 million lease termination fee received from the prior tenant at the Global Inpatient Rehab facility, which was offset by a $0.7 million write off of the straight-line receivable. The Company entered into a lease with a new tenant, Children’s Health System of Texas, and expects net operating income to normalize throughout the remainder of 2016.
Nine Months Ended September 30, | ||||||||||||||||
2016 | 2015 | $ Change | % Change | |||||||||||||
Triple-Net Leased Properties — Net operating income | ||||||||||||||||
Rental revenue | $ | 6,301,000 | $ | 6,986,000 | $ | (685,000 | ) | (10 | )% | |||||||
Tenant reimbursement and other income | 2,064,000 | 917,000 | 1,147,000 | 125 | % | |||||||||||
Less: | ||||||||||||||||
Property operating and maintenance expenses | 929,000 | 921,000 | 8,000 | 1 | % | |||||||||||
Total portfolio net operating income | $ | 7,436,000 | $ | 6,982,000 | $ | 454,000 | 7 | % |
16 |
Medical Office Building Properties
Total revenue for medical office building properties includes rental revenue and expense reimbursements from tenants. Property operating and maintenance expenses include utilities, repairs and maintenance, insurance and property taxes. Net operating income for the nine months ended September 30, 2016 of $0.6 million is comparable to net operating income for the nine months ended September 30, 2015.
Nine Months Ended September 30, | ||||||||||||||||
2016 | 2015 | $ Change | % Change | |||||||||||||
Medical Office Building Properties — Net operating income | ||||||||||||||||
Rental revenue | $ | 640,000 | $ | 647,000 | $ | (7,000 | ) | (1 | )% | |||||||
Resident services and fee income | - | 14,000 | (14,000 | ) | (100 | )% | ||||||||||
Tenant reimbursement and other income | 234,000 | 220,000 | 14,000 | 6 | % | |||||||||||
Less: | ||||||||||||||||
Property operating and maintenance expenses | 275,000 | 245,000 | 30,000 | 12 | % | |||||||||||
Total portfolio net operating income | $ | 599,000 | $ | 636,000 | $ | (37,000 | ) | (6 | )% |
Unallocated (expenses) income
General and administrative expenses decreased to $1.5 million for the nine months ended September 30, 2016 from $2.1 million for the nine months ended September 30, 2015. The decrease was primarily due to $0.6 million in costs incurred during the nine months ended September 30, 2015 by our board of directors, along with its advisors, to evaluate strategic alternatives in order to maximize shareholder value.
Asset management fees for the nine months ended September 30, 2016 decreased to $3.2 million from $4.5 million in the nine months ended September 30, 2015 as a result of the advisor achieving the maximum fee amount for the period of February 11, 2016 through February 10, 2017 during the period ended September 30, 2016.
Real estate acquisition costs for the nine months ended September 30, 2016 decreased to $0.0 million from $1.5 million for the nine months ended September 30, 2015 as a result of no acquisition activity for the nine months ended September 30, 2016.
Depreciation and amortization for the nine months ended September 30, 2016 decreased to $12.7 million from $15.4 million for the nine months ended September 30, 2015, due to higher depreciation and amortization in 2015 resulting from acquisitions, particularly amortization of the in-place leases for senior living facilities acquired in the fourth quarter of 2014 and the first and second quarters of 2015. These assets are generally amortized in the first twelve months after closing.
Interest expense, net, for the nine months ended September 30, 2016 increased to $11.8 million from $10.3 million for the nine months ended September 30, 2015, primarily as a result of the debt incurred for acquisitions that occurred in the first and second quarters of 2015 and the consolidation of The Parkway, which began operations in the third quarter of 2015.
The change in fair value of contingent consideration decreased to $0.2 million for the nine months ended September 30, 2016 from $1.0 million for the nine months ended September 30, 2015 due to a change in the projected timing to achieve certain specified net operating income thresholds for the Sumter Grand and Armbrook Village properties. During the nine months ended September 30, 2016, the Company paid the entire Gables of Hudson earnout of $2.2 million and $1.8 million of the Armbrook Village earnout, as the first tier of the net operating income threshold was met in June 2016.
The Company recognized a loss on debt extinguishment in the amount of $0.4 million for the nine months ended September 30, 2016, as a result of the refinancing of the secured loan agreements with KeyBank for Mesa Vista Inn Health Center, Live Oaks of Hammond, Live Oaks of Slidell, Spring Village at Wildewood, Gables of Hudson, Sumter Place, Sumter Grand and Woodbury Mews.
The Company recognized a loss from unconsolidated entities of $0.2 million for the nine months ended September 30, 2016, which was comparable to the loss of $0.3 million recognized for nine months ended September 30, 2015. The Company’s allocation of loss from unconsolidated entities relates to the operations of Buffalo Crossings and Physicians Center MOB.
During the nine months ended September 30, 2016 and 2015, we recognized state and federal income tax benefit of approximately $1.3 million and $2.6 million, respectively, related to our senior living properties consolidated into our Master TRS. This decrease relates to the lower amortization of in-place lease value associated with properties acquired in late 2014 and early 2015.
Liquidity and Capital Resources
On June 19, 2013, we filed a registration statement on Form S-3 to register up to $99,000,000 of shares of common stock to be offered to our existing stockholders pursuant to the DRIP Offering. The purchase price for shares offered pursuant to the DRIP Offering is equal to the most recently announced estimated per-share value, as of the date the shares are purchased under the distribution reinvestment plan. The DRIP Offering shares were initially offered at a purchase price of $10.02; effective February 28, 2014, DRIP offering shares were offered at a purchase price of $11.63 per share; and effective March 23, 2016 DRIP offering shares are being offered at $12.45, which is our most recent estimated per-share value.
On February 10, 2013, we entered into the KKR Equity Commitment for the purpose of obtaining equity funding to finance investment opportunities. Pursuant to the KKR Equity Commitment, we could issue and sell to the Investor and its affiliates on a private placement basis from time to time over a period of up to three years, up to $158.7 million in aggregate issuance amount of preferred securities in the Company and the Operating Partnership. As of September 30, 2016, the Company has received $156.3 million of the total commitment and $2.3 million of equity remains to be funded in connection with the Georgetown Loan. No securities remain issuable under the KKR Equity Commitment.
As of September 30, 2016, we had issued and outstanding 11,524,370 shares of common stock, and 1,000 shares of 3% Senior Cumulative Preferred Stock, Series C (the “Series C Preferred Stock”). All 1,000 shares of the Series C Preferred Stock were issued to the Investor pursuant to the KKR Equity Commitment. In addition, as of September 30, 2016 the Operating Partnership had issued and outstanding 11,544,370 Common Units, 1,000 Series A Preferred Units (the “Series A Preferred Units”), and 1,586,000 Series B Convertible Preferred Units (the “Series B Preferred Units”). As of September 30, 2016, we held all of the issued and outstanding Common Units and all of the issued and outstanding Series A Preferred Units. All of the issued and outstanding Series B Preferred Units were issued to the Investor in connection with the KKR Equity Commitment.
We expect that our primary sources of capital will consist of debt financing, net cash flows from operations and net proceeds from preferred units of partnership interest in our Operating Partnership committed and funded in accordance with the terms of the KKR Equity Commitment. We expect that our primary uses of capital will be for real estate investments, including earnouts and promote monetization payments, payment of tenant improvements and capital improvements, operating expenses, including interest expense on any outstanding indebtedness, reducing outstanding indebtedness and for the payment of distributions.
We intend to own our stabilized properties with low to moderate levels of debt financing. We incur moderate to high levels of indebtedness when acquiring development or value-added properties and possibly other real estate investments. For our stabilized core plus properties, our long-term goal is to use low to moderate levels of debt financing with leverage ranging from 50% to 65% of the value of the asset. For development and value-added properties, our goal is to acquire and develop or redevelop these properties using moderate to high levels of debt financing with leverage ranging from 65% to 75% of the cost of the asset. Once these properties are developed, redeveloped and stabilized with tenants, we will reduce the levels of debt to fall within the loan to value target debt ranges appropriate for core properties. While we seek to fall within the outlined targets on a portfolio basis, for any specific property we may exceed these estimates. To the extent we do not have sufficient proceeds to reduce debt financing to the target ranges within a reasonable time as determined by our board of directors, we will endeavor to raise additional equity or sell properties to repay such debt so that we will own our properties with low to moderate levels of permanent financing. In the event that we are unable to raise additional equity, our ability to diversify our investments may be diminished.
17 |
In addition, one of our principal liquidity requirements includes debt service payments and the repayment of maturing debt. As of September 30, 2016, our notes payable were $357.4 million ($353.2 million, net of discount and deferred financing costs).
We are required by the terms of the applicable loan documents to meet certain financial covenants, such as debt service coverage ratios, rent coverage ratios and reporting requirements. As of September 30, 2016, we were in compliance with all such covenants and requirements.
As of September 30, 2016 we had approximately $36.3 million in cash and cash equivalents on hand. Our liquidity will increase from the sale of common stock pursuant to our DRIP Offering, by reducing the amount of dividends to be paid in cash, if refinancing results in excess loan proceeds, and increased cash flows from operations. The Company’s liquidity will decrease as funds are expended in connection with real estate investments, including earnouts and promote monetization payments for the payment of tenant improvements and capital improvements and operating expenses, including interest expense on any outstanding indebtedness, and if distributions are made in excess of cash from operations.
Cash flows provided by operating activities for the nine months ended September 30, 2016 and 2015 were $18.6 million and $13.2 million, respectively. The increase in cash flows from operations was primarily due to an increase in portfolio net operating income of $5.6 million and the timing of cash receipts and payments.
Cash flows used in investing activities for the nine months ended September 30, 2016 and 2015 were $24.0 million and $87.1 million, respectively. The decrease was due primarily to the acquisitions of Sumter Grand, Gables of Kentridge and Armbrook Village for $69.3 million in 2015.
Cash flows provided by financing activities for the nine months ended September 30, 2016 and 2015 were $18.9 million and $65.5 million, respectively. The decrease is primarily a result of activity related to the KKR Equity Commitment and proceeds from and repayments of notes payable for the period ended September 30, 2016 as compared to the period ended September 30, 2015. During the nine months ended September 30, 2016, the Company received $18.3 million of net proceeds from the issuance of Series B Preferred Units related to the KKR Equity Commitment. Additionally, the Company received proceeds from notes payable of $130.8 million related to the Participation Agreement, refinance activity and draws on debt for The Parkway, the Accel at Golden development, and Gables of Hudson. These proceeds were offset with $112.1 million of repayments of notes payable related to the Company’s refinance activity, distributions paid to stockholders of $8.7 million and distributions paid to noncontrolling interests of $4.0 million. During the nine months ended September 30, 2015, the Company received $36.7 million of net proceeds from the issuance of Series B Preferred Units related to the KKR Equity Commitment and received proceeds from notes payable of $43.7 million related to the acquisitions of Sumter Grand, Gables of Kentridge and Armbrook Village. These proceeds were offset by the distributions paid to stockholders of $4.0 million and distributions paid to noncontrolling interests of $7.8 million.
We expect to have sufficient cash available from cash on hand and operations to fund recurring capital improvements and principal payments due on our borrowings in the next twelve months. We expect to fund stockholder distributions from cash on hand and from the excess cash provided by operations over required capital improvements and debt payments. This excess may be insufficient to make distributions at the current level or at all.
There may be a delay between the generation of cash available for investment and funding of investments. During this period, proceeds may be temporarily invested in short-term, liquid investments that could yield lower returns than investments in real estate.
Potential future sources of capital include proceeds from future equity offerings, proceeds from secured or unsecured financings from banks or other lenders, proceeds from the sale of properties and undistributed funds from operations.
Funds from Operations and Modified Funds from Operations
Funds from operations (“FFO”) is a non-GAAP financial measure that is widely recognized as a measure of REIT operating performance. We compute FFO in accordance with the definition outlined by the National Association of Real Estate Investment Trusts (“NAREIT”). NAREIT defines FFO as net income (loss), computed in accordance with GAAP, excluding extraordinary items, as defined by GAAP, and gains (or losses) from sales of property, plus depreciation and amortization on real estate assets, and after adjustments for unconsolidated partnerships, joint ventures, noncontrolling interests and subsidiaries. Our FFO may not be comparable to FFO reported by other REITs that do not define the term in accordance with the current NAREIT definition or that interpret the current NAREIT definition differently than we do. We believe that FFO is helpful to investors and our management as a measure of operating performance because it excludes depreciation and amortization, gains and losses from property dispositions, and extraordinary items, and as a result, when compared year to year, reflects the impact on operations from trends in occupancy rates, rental rates, operating costs, development activities, general and administrative expenses, and interest costs, which is not immediately apparent from net income. Historical cost accounting for real estate assets in accordance with GAAP implicitly assumes that the value of real estate diminishes predictably over time. Since real estate values have historically risen or fallen with market conditions, many industry investors and analysts have considered the presentation of operating results for real estate companies that use historical cost accounting alone to be insufficient. As a result, our management believes that the use of FFO, together with the required GAAP presentations, provide a more complete understanding of our performance. Factors that impact FFO include fixed costs, delay in buying assets, lower yields on cash held in accounts pending investment, income from portfolio properties and other portfolio assets, interest rates on acquisition financing and operating expenses. FFO should not be considered as an alternative to net income (loss), as an indication of our performance, nor is it indicative of funds available to fund our cash needs, including our ability to make distributions, as well as dividend sustainability.
Changes in the accounting and reporting rules under GAAP have prompted a significant increase in the amount of non-cash and non-operating items included in FFO, as defined. Therefore, we use modified funds from operations (“MFFO”), which excludes from FFO real estate acquisition expenses, and non-cash amounts related to straight line rent to further evaluate our operating performance. We compute MFFO consistently with the definition suggested by the Investment Program Association (the “IPA”), the trade association for direct investment programs (including non-listed REITs). However, certain adjustments included in the IPA’s definition are not applicable to us and are therefore not included in the foregoing definition.
We believe that MFFO is a helpful measure of operating performance because it excludes costs that management considers more reflective of investing activities or non-operating changes. Accordingly, we believe that MFFO can be a useful metric to assist management, investors and analysts in assessing the sustainability of our operating performance. As explained below, management’s evaluation of our operating performance excludes the items considered in the calculation based on the following considerations:
• | Adjustments for straight line rents. Under GAAP, rental income recognition can be significantly different than underlying contract terms. By adjusting for these items, MFFO provides useful supplemental information on the economic impact of our lease terms and presents results in a manner more consistent with management’s analysis of our operating performance. | |
• | Real estate acquisition costs. In evaluating investments in real estate, including both business combinations and investments accounted for under the equity method of accounting, management’s investment models and analysis differentiate costs to acquire the investment from the operations derived from the investment. These acquisition costs have been funded from the proceeds of our initial public offering and other financing sources and not from operations. We believe by excluding expensed acquisition costs, MFFO provides useful supplemental information that is comparable for each type of our real estate investments and is consistent with management’s analysis of the investing and operating performance of our properties. Real estate acquisition expenses include those paid to our advisor and to third parties. | |
• | Non-recurring gains or losses included in net income from the extinguishment or sale of debt. | |
• | Unrealized gains or losses resulting from consolidation to, or deconsolidation from equity accounting. | |
• | Elimination of adjustments relating to contingent purchase price obligations where such adjustments have been included in the derivation of GAAP net income. |
18 |
FFO or MFFO should not be considered as an alternative to net income (loss) nor as an indication of our liquidity. Nor is either indicative of funds available to fund our cash needs, including our ability to make distributions. Both FFO and MFFO should be reviewed along with other GAAP measurements. Our FFO and MFFO as presented may not be comparable to amounts calculated by other REITs. In addition, FFO and MFFO presented for different periods may not be directly comparable.
We believe that MFFO is helpful as a measure of operating performance because it excludes costs that management considers more reflective of investing activities or non-operating changes.
Our calculations of FFO and MFFO for the three and nine months ended September 30, 2016 and 2015 are presented below:
Three Months Ended | Nine Months Ended | |||||||||||||||
September 30, | September 30, | |||||||||||||||
2016 | 2015 | 2016 | 2015 | |||||||||||||
Net loss attributable to common stockholders | $ | (52,000 | ) | $ | (2,956,000 | ) | $ | (2,017,000 | ) | $ | (9,370,000 | ) | ||||
Adjustments: | ||||||||||||||||
Real estate depreciation and amortization | 3,763,000 | 5,459,000 | 12,717,000 | 15,434,000 | ||||||||||||
Joint venture depreciation and amortization | 140,000 | 87,000 | 416,000 | 311,000 | ||||||||||||
Funds from operations (FFO) attributable to common stockholders | 3,851,000 | 2,590,000 | 11,116,000 | 6,375,000 | ||||||||||||
Adjustments: | ||||||||||||||||
Straight-line rent and above/below market lease amortization | (176,000 | ) | (211,000 | ) | 8,000 | (652,000 | ) | |||||||||
Real estate acquisition costs | - | 111,000 | - | 1,461,000 | ||||||||||||
Change in fair value of contingent consideration | (103,000 | ) | 402,000 | 203,000 | 1,002,000 | |||||||||||
Loss on debt extinguishment | 378,000 | - | 378,000 | - | ||||||||||||
Modified funds from operations (MFFO) attributable to common stockholders | 3,950,000 | 2,892,000 | 11,705,000 | 8,186,000 | ||||||||||||
Weighted average shares | 11,522,649 | 11,493,442 | 11,513,008 | 11,483,534 | ||||||||||||
FFO per weighted average shares | $ | 0.33 | $ | 0.23 | $ | 0.97 | $ | 0.56 | ||||||||
MFFO per weighted average shares | $ | 0.34 | $ | 0.25 | $ | 1.02 | $ | 0.71 |
Distributions Available to Common Stockholders
Beginning April 1, 2013, our board of directors declared distributions for daily record dates occurring after April 1, 2013 in amounts per share that, if declared and paid each day for a 365-day period, would equate to an annualized rate of $0.50 per share (5.00% based on the initial purchase price of our common stock of $10.00).
The declaration of distributions is at the discretion of our board of directors and our board will determine the amount of distributions on a regular basis. The amount of distributions will depend on our funds from operations, financial condition, capital requirements, annual distribution requirements under the REIT provisions of the Internal Revenue Code and other factors our board of directors deems relevant.
Distributions Declared(1) | Distributions | Cash Flow from | Net (Loss) | |||||||||||||||||||||
Period | Cash | Reinvested | Total | Paid | Operations | Income | ||||||||||||||||||
First quarter 2015 | $ | 1,330,000 | $ | 85,000 | $ | 1,415,000 | $ | 1,355,000 | $ | 3,348,000 | $ | (733,000 | ) | |||||||||||
Second quarter 2015 | 1,347,000 | 85,000 | 1,432,000 | 1,330,000 | 4,369,000 | (1,498,000 | ) | |||||||||||||||||
Third quarter 2015 | 1,363,000 | 86,000 | 1,449,000 | 1,347,000 | 5,515,000 | (509,000 | ) | |||||||||||||||||
$ | 4,040,000 | $ | 256,000 | $ | 4,296,000 | $ | 4,032,000 | $ | 13,232,000 | $ | (2,740,000 | ) | ||||||||||||
First quarter 2016 | $ | 1,342,000 | $ | 89,000 | $ | 1,431,000 | $ | 1,362,000 | $ | 6,871,000 | $ | 2,388,000 | ||||||||||||
Second quarter 2016 | 1,343,000 | 88,000 | 1,431,000 | 1,342,000 | 4,607,000 | 1,264,000 | ||||||||||||||||||
Third quarter 2016 | 1,358,000 | 91,000 | 1,449,000 | 1,345,000 | 7,072,000 | 2,958,000 | ||||||||||||||||||
$ | 4,043,000 | $ | 268,000 | $ | 4,311,000 | $ | 4,049,000 | $ | 18,550,000 | $ | 6,610,000 |
(1) | In order to meet the requirements for being treated as a REIT under the Internal Revenue Code, we must pay distributions to our stockholders each taxable year equal to at least 90% of our net ordinary taxable income. |
For the nine months ended September 30, 2016 and 2015, we declared distributions, including distributions reinvested, aggregating approximately $4.0 million and $4.0 million, respectively to our stockholders. The distributions declared in the third quarter of 2016 to be reinvested in the Company’s common stock resulted in 7,284 shares of common stock being issued in October 2016. FFO for the nine months ended September 30, 2016 was approximately $11.1 million and cash flow from operations was approximately $18.6 million. We funded our total distributions paid with cash flows from operations. For the purposes of determining the source of our distributions paid, we assume first that we use cash flows from operations from the relevant periods to fund distribution payments. See the reconciliation of FFO to net loss above.
Item 3. | Quantitative and Qualitative Disclosures About Market Risk |
Market risk includes risks that arise from changes in interest rates, foreign currency exchange rates, commodity prices, equity prices and other market changes that affect market sensitive instruments. We invest our cash and cash equivalents in government-backed securities and FDIC-insured savings accounts which, by their nature, are subject to interest rate fluctuations. However, we believe that the primary market risk to which we will be exposed is interest rate risk relating the variable portion of our debt financing. As of Septemebr 30, 2016, we had approximately $162.7 million of variable rate debt, the majority of which is at a rate tied to short-term LIBOR. A 1.0% change in one-Month LIBOR would result in a change in annual interest expense of approximately $1.6 million per year. Our interest rate risk management objectives are to monitor and manage the impact of interest rate changes on earnings and cash flows. We may use certain derivative financial instruments such as interest rate swaps and caps in order to mitigate our interest rate risk on variable rate debt. We will not enter into derivative or interest rate transactions for speculative purposes.
In addition to changes in interest rates, the fair value of our real estate is subject to fluctuations based on changes in the real estate capital markets, market rental rates for healthcare facilities, local, regional and national economic conditions and changes in the credit worthiness of tenants. All of these factors may also affect our ability to refinance our debt if necessary.
Item 4. | Controls and Procedures |
We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our Securities Exchange Act reports is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our senior management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure. Our Chief Executive Officer and Chief Financial Officer have reviewed the effectiveness of our disclosure controls and procedures and have concluded that the disclosure controls and procedures were effective as of the end of the period covered by this report.
19 |
Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, we evaluated our disclosure controls and procedures, as such term is defined under Rule 13a-15(e) promulgated under the Securities and Exchange Act of 1934. In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management is required to apply its judgement in evaluating the cost-benefit relationship of possible controls and procedures.
There have been no changes in our internal control over financial reporting during out most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
Item 6. | Exhibits |
Ex. | Description | |
3.1 | Articles of Amendment and Restatement of the Registrant, as amended on December 29, 2009 and January 24, 2012 (incorporated by reference to Exhibit 3.1 to the Registrant’s annual report on Form 10-K for the year ended December 31, 2011). | |
3.2 | Articles of Amendment of the Registrant, dated August 6, 2013 (incorporated by reference to Exhibit 3.2 to the Registrant’s quarterly report on Form 10-Q for the quarterly period ended June 30, 2013). | |
3.3 | Articles Supplementary, 3% Senior Cumulative Preferred Stock, Series A, dated August 6, 2013 (incorporated by reference to Exhibit 3.3 to the Registrant’s quarterly report on Form 10-Q for the quarterly period ended June 30, 2013). | |
3.4 | Articles Supplementary, 3% Senior Cumulative Preferred Stock, Series C, dated August 6, 2013 (incorporated by reference to Exhibit 3.4 to the Registrant’s quarterly report on Form 10-Q for the quarterly period ended June 30, 2013). | |
3.5 | Second Amended and Restated Bylaws of the Registrant as adopted on August 6, 2013 as amended by Amendment No. 1 to the Second Amendment and Restated Bylaws of the Registrant, effective as of March 20, 2015 (incorporated by reference to Exhibit 3.5 to the Registrant’s annual report on Form 10-K for the year ended December 31, 2014). | |
3.6 | Second Amended and Restated Limited Partnership Agreement of Sentio Healthcare Properties OP, L.P., dated August 5, 2013 (incorporated by reference to Exhibit 3.6 to the Registrant’s quarterly report on Form 10-Q for the quarterly period ended June 30, 2013). | |
3.7 | First Amendment dated December 22, 2014 to the Second Amendment and Restated Limited Partnership Agreement of Sentio Healthcare Properties OP, L.P., dated August 5, 2013 (incorporated by reference to Exhibit 3.1 to the Registrant’s current report on Form 8-K filed on December 30, 2014). | |
3.8 | Second Amendment to the Second Amendment and Restated Limited Partnership Agreement of Sentio Healthcare Properties OP, L.P. (incorporated by reference to Exhibit 3.1 to the Registrant’s current report on Form 8-K filed on September 7, 2016). | |
4.1 | Form of Distribution Reinvestment Enrollment Form (incorporated by reference to Appendix A to the Registrant’s prospectus filed on June 19, 2013). | |
4.2 | Statement regarding restrictions on transferability of the Registrant’s shares of common stock (to appear on stock certificate or to be sent upon request and without charge to stockholders issued shares without certificates) (incorporated by reference to Exhibit 4.2 to Pre-Effective Amendment No. 2 to the Registration Statement on Form S-11 (No. 333-139704) filed on June 15, 2007 (“Pre-Effective Amendment No. 2”). | |
4.3 | Second Amended and Restated Distribution Reinvestment Plan (incorporated by reference to Appendix B to the Registrant’s prospectus filed on June 19, 2013). | |
10.1 | Sentio Healthcare Properties, Inc. Regular Quarterly Dividend Policy (incorporated by reference to Exhibit 10.1 to the Registrant’s current report on Form 8-K filed on September 7, 2016). | |
10.2 | Multifamily Loan and Security Agreement dated August 19, 2016 between Wildewood Owner, LLC and KeyBank National Association (filed herewith). | |
10.3 | Multifamily Loan and Security Agreement dated August 19, 2016 between Gables of Hudson, LLC and KeyBank National Association (filed herewith). | |
10.4 | Multifamily Loan and Security Agreement dated August 19, 2016 between Sumter Place Owner, LLC and KeyBank National Association (filed herewith). | |
10.5 | Secured Loan Agreement dated August 19, 2016 by and among Sentio Landlord Hammond, LLC, Sentio Landlord Slidell, LLC, MVI Health Center, LP, Woodbury Mews III Urban Renewal, LLC, Woodbury Mews IV Urban Renewal, LLC, Retirement Two, LLC and KeyBank National Association (filed herewith). | |
10.6 | Guaranty Agreement dated August 19, 2016 by the Registrant, Sentio Healthcare Properties, OP, LP and Sentio Healthcare Properties, Inc. for the benefit of KeyBank National Association (filed herewith). | |
31.1 | Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith). | |
31.2 | Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith). | |
32.1 | Certification of Chief Executive Officer and Chief Financial Officer, pursuant to 18 U.S.C. Section 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002 (filed herewith). | |
101.INS | XBRL Instance Document (filed herewith). | |
101.SCH | XBRL Taxonomy Extension Schema (filed herewith). | |
101.CAL | XBRL Taxonomy Extension Calculation Linkbase (filed herewith). | |
101.DEF | XBRL Taxonomy Extension Definition Linkbase (filed herewith). | |
101.LAB | XBRL Taxonomy Extension Label Linkbase (filed herewith). | |
101.PRE | XBRL Taxonomy Extension Presentation Linkbase (filed herewith). |
20 |
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this quarterly report to be signed on its behalf by the undersigned, thereunto duly authorized this 14th day of November 2016.
SENTIO HEALTHCARE PROPERTIES, INC. | ||
By: | /s/ JOHN MARK RAMSEY | |
John Mark Ramsey President, Chief Executive Officer and Director | ||
(Principal Executive Officer) | ||
By: | /s/ SHARON C. KAISER | |
Sharon C. Kaiser Chief Financial Officer; Treasurer and Secretary | ||
(Principal Financial Officer and Principal Accounting Officer) |
21 |